Processing 00000000.tx.1: A Novel Protein Activity Mediates DNA Binding of an ATR-ATRIP Complex* Ryan D. 

Phrase: "A Novel Protein Activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1537044:protein activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "Mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "DNA Binding of an ATR-ATRIP Complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1148673:DNA Binding [Genetic Function]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "* Ryan D."
Processing 00000000.tx.2: Bomgarden, Dawn Yean, Muh-Ching Yee, and Karlene A. 

Phrase: "Bomgarden,"

Phrase: "Dawn Yean,"

Phrase: "Muh-Ching Yee,"

Phrase: "and"

Phrase: "Karlene A."
Processing 00000000.tx.3: Cimprich From the Department of Molecular Pharmacology, Stanford University, Stanford, California 94305-5441 Received for publication, October 8, 2003 , and in revised form, December 22, 2003.  

Phrase: "Cimprich From the Department of Molecular Pharmacology,"

Phrase: "Stanford University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Stanford,"

Phrase: "California 94305-5441"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006754:California [Geographic Area]
   827   C3146274:California [Plant]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "October 8,"

Phrase: "2003 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "December 22,"

Phrase: "2003."
Processing 00000000.tx.4: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  The function of the ATR (ataxia-telangiectasia mutated and Rad3-related)-ATRIP (ATR-interacting protein) protein kinase complex is central to the cellular response to replication stress and DNA damage. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The function of the ATR (ataxia-telangiectasia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "and"

Phrase: "Rad3-related"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0439849:Related [Qualitative Concept]
   861   C0445223:Related [Finding]
   789 E C0080103:Relation [Family Group]
   789 E C0869014:Relations [Social Behavior]

Phrase: ")-"

Phrase: "ATRIP"

Phrase: "(ATR-interacting protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0967200:ATR-Interacting Protein [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2243119:ATR-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "protein kinase complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1523872:protein complex [Cell Component]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]
   734   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "central to the cellular response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205099:Central [Spatial Concept]
   760   C1879652:Central - [Laboratory Procedure]

Phrase: "to replication stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "DNA damage."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]
Processing 00000000.tx.5: In order to better understand the function of this complex, we have studied its interaction with DNA. 

Phrase: "In order to better"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0332272:Better [Qualitative Concept]
   827   C1705175:Order [Intellectual Product]
   827   C1705176:Order [Qualitative Concept]
   827   C1705177:Order [Classification]
   827   C1705178:Order [Activity]
   827   C1882348:Order [Qualitative Concept]
   793 E C0205170:Well [Qualitative Concept]
   793 E C3146287:Well [Manufactured Object]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the function of this complex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "its interaction with DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.6: We find that both ATR and ATRIP associate with chromatin in vivo, and they exist as a large molecular weight complex that can bind single-stranded (ss)DNA cellulose in vitro. 

Phrase: "We"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that"

Phrase: "both ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "associate with chromatin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
   790   C0750490:Associate [Idea or Concept]
   790   C1325550:chromatin [Cell Component]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "they"

Phrase: "exist as a large molecular weight complex"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0026385:Molecular Weight [Quantitative Concept]
   748   C0005910:weight [Organism Attribute]
   748   C0043100:Weight [Quantitative Concept]
   748   C0439855:Complex [Qualitative Concept]
   748   C0549177:Large [Quantitative Concept]
   748   C1305866:weight [Diagnostic Procedure]
   748   C1521991:Molecular [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]
   748   C1705104:Weight [Idea or Concept]
   748   C2987476:Exist [Conceptual Entity]

Phrase: "that"

Phrase: "can"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "single-stranded"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   964   C1979975:Single strand [Qualitative Concept]
   861   C0037179:Single [Population Group]
   861   C0087136:single [Finding]
   861   C0205171:Single [Quantitative Concept]
   789   C1704972:Strand [Spatial Concept]
   789   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(ss)DNA cellulose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0058604:DNA-cellulose [Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.7: Although replication protein A (RPA) is sufficient for the recruitment of ATRIP to ssDNA, we show that a distinct ATR-ATRIP complex is able to bind to DNA with lower affinity in the absence of RPA. 

Phrase: "Although"

Phrase: "replication protein A (RPA)"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]

Phrase: "is"

Phrase: "sufficient for the recruitment of ATRIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205410:Sufficient [Qualitative Concept]

Phrase: "to ssDNA,"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a distinct ATR-ATRIP complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C2611008:ATR-ATRIP complex [Cell Component]
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "bind to DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "with lower affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of RPA."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]
Processing 00000000.tx.8: In this latter complex, we show that neither ATR nor ATRIP are able to bind DNA individually, nor do they bind DNA in a cooperative manner. 

Phrase: "In this latter complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "neither ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "nor"

Phrase: "ATRIP"

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA individually,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "nor"

Phrase: "do"

Phrase: "they"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA in a cooperative manner."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.9: However, the addition of HeLa nuclear extract is able to reconstitute the DNA binding of both ATR and ATRIP, suggesting the requirement for an additional protein activity. 

Phrase: "However,"

Phrase: "the addition of HeLa nuclear extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "reconstitute"

Phrase: "the DNA binding of both ATR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1148673:DNA Binding [Genetic Function]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "ATRIP,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the requirement for an additional protein activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0556043:Protein requirement [Finding]
   748   C1514873:Requirement [Functional Concept]
Processing 00000000.tx.10: We also show that ATR is necessary for ATRIP to bind DNA in this low affinity mode and to form a large DNA binding complex. 

Phrase: "We also"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "is"

Phrase: "necessary for ATRIP to"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA in this low affinity mode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a large DNA binding complex."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C1148673:DNA Binding [Genetic Function]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C0439855:Complex [Qualitative Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.11: These observations suggest that there are at least two in vitro ATR-ATRIP DNA binding complexes, one which binds DNA with high affinity in an RPA-dependent manner and a second, which binds DNA with lower affinity in an RPA-independent manner but which requires an as of yet unidentified protein.  

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "are at least two in vitro ATR-ATRIP DNA binding complexes,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   761   C2611008:ATR-ATRIP complex [Cell Component]
   756   C0021135:In Vitro [Intellectual Product]
   756   C1148673:DNA Binding [Genetic Function]
   756   C1533691:in vitro [Qualitative Concept]
           vitro
   756   C2827718:In Vitro [Functional Concept]
   738   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0205448:Two [Quantitative Concept]
   738   C0243122:binding [Functional Concept]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1551058:Are [Quantitative Concept]
   738   C1704241:Complexes [Chemical Viewed Structurally]
   738   C3540546:ATR [Gene or Genome]
   704 E C0439855:Complex [Qualitative Concept]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "which"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA with high affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in an RPA-dependent manner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1167121:replication protein A [Cell Component]

Phrase: "and"

Phrase: "a second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "which"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA with lower affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in an RPA-independent manner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1167121:replication protein A [Cell Component]

Phrase: "but"

Phrase: "which"

Phrase: "requires"

Phrase: "an as of yet unidentified protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205427:Unidentified [Qualitative Concept]
Processing 00000000.tx.12: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Cell cycle checkpoints are highly conserved signal transduction pathways that alert the cell to the presence of DNA damage or replication stress (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell cycle checkpoints"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1155874:Cell Cycle Checkpoints [Cell Function]
           Checkpoint
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]

Phrase: "are"

Phrase: "highly conserved signal transduction pathways"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0086982:Signal Transduction Pathways [Molecular Function]
   853   C0037080:Signal Pathways [Molecular Function]
   840   C0037083:Signal Transduction [Cell Function]
   804   C1160185:transduction [Organism Function]
   804   C1704259:Pathways [Molecular Function]
   804   C1705987:Pathways [Conceptual Entity]
   804   C1710082:Signal [Phenomenon or Process]

Phrase: "that"

Phrase: "alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "the cell to the presence of DNA damage"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007634:THE CELL [Cell]
           Cell
   767   C0599732:cell damage [Cell or Molecular Dysfunction]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "replication stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: Activation of these pathways triggers a variety of downstream events, including cell cycle arrest, DNA repair or apoptosis. 

Phrase: "Activation of these pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "a variety of downstream events,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cell cycle arrest,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155873:Cell Cycle Arrest [Cell Function]
  1000   C1516332:Cell Cycle Arrest [Cell Function]
   827   C0237477:Arrest [Temporal Concept]
   827   C0392351:arrest [Governmental or Regulatory Activity]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]

Phrase: "DNA repair"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012899:DNA Repair [Genetic Function]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0043240:Repair, NOS [Organism Function]
   861   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.14: Defects in cell cycle checkpoint proteins can lead to increased genomic instability, a hallmark of tumor cells. 

Phrase: "Defects in cell cycle checkpoint proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   867   C0243021:Cell Cycle Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "lead to increased genomic instability,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0919532:Genomic Instability [Cell or Molecular Dysfunction]
   797   C0861064:increased lead [Finding]
   760   C0017428:Genomic [Gene or Genome]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0887950:genomic [Biomedical Occupation or Discipline]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1444783:Instability [Finding]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "a hallmark of tumor cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   781   C1512330:Hallmark Cell [Cell]
Processing 00000000.tx.15: Central to this pathway are a family of conserved phosphatidylinositol kinase-related (PIK-related)1 protein kinases. 

Phrase: "Central to this pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205099:Central [Spatial Concept]
   770   C1879652:Central - [Laboratory Procedure]

Phrase: "are"

Phrase: "a family of conserved phosphatidylinositol kinase-related (PIK-related)"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   774   C0031727:Kinase Family [Amino Acid, Peptide, or Protein,Enzyme]
           Kinase
   748   C0015576:Family [Family Group]
   748   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C1704727:Family [Conceptual Entity]
   748   C2348046:Phosphatidylinositol [Lipid]
   714 E C0163712:Relate [Organic Chemical]

Phrase: "1 protein kinases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.16: In Saccharomyces cerevisiae and Schizosaccharomyces pombe, Mec1 and Rad3 respectively, are the PIK-related kinases activated by both DNA-damaging agents and replication inhibitors (2). 

Phrase: "In Saccharomyces cerevisiae"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036025:Saccharomyces cerevisae [Fungus]
   861   C0036024:Saccharomyces [Fungus]

Phrase: "and"

Phrase: "Schizosaccharomyces pombe,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0178453:Schizosaccharomyces pombe [Fungus]
   861   C0036361:Schizosaccharomyces [Fungus]

Phrase: "Mec1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332120:MEC1 [Gene or Genome]

Phrase: "and"

Phrase: "Rad3 respectively,"

Phrase: "are"

Phrase: "the PIK-related kinases"

Phrase: "activated by both DNA-damaging agents"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1879547:Activated [Activity]
   719   C0450442:Agent [Chemical Viewed Functionally]
   719   C1254351:Agent [Pharmacologic Substance]
   719 E C1515877:Activate [Functional Concept]
   719   C1521826:Agent [Intellectual Product]

Phrase: "and"

Phrase: "replication inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.17: Among the PIK-related kinases identified in mammalian cells, DNA-PK (DNA-dependent protein kinase), ATM (ataxia telangiectasia-mutated), and ATR (ATM and Rad3-related) are known to be involved in the response to DNA damage (3, 4). 

Phrase: "Among the PIK-related kinases"

Phrase: "identified in mammalian cells,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   819   C0805527:Cells identified [Laboratory or Test Result]
   816   C1512977:Mammalian Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0024660:Mammalian [Mammal]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "DNA-PK (DNA-dependent protein kinase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   919   C0212694:DNA-dependent protein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   919   C1335262:DNA-DEPENDENT PROTEIN KINASE [Gene or Genome]
   895   C0032545:DNA Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   895   C1418707:DNA KINASE [Gene or Genome]
   827   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "ATM (ataxia telangiectasia-mutated"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   923   C0298973:Ataxia Telangiectasia Mutated [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0919524:ataxia telangiectasia mutated [Gene or Genome]
   812   C1705285:Mutated [Cell or Molecular Dysfunction]
   779 E C1513776:Mutate [Genetic Function]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "ATR (ATM"

Phrase: "and"

Phrase: "Rad3-related"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0439849:Related [Qualitative Concept]
   861   C0445223:Related [Finding]
   789 E C0080103:Relation [Family Group]
   789 E C0869014:Relations [Social Behavior]

Phrase: ")"

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in the response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0871261:Response [Organism Attribute]
   770   C1314939:Involved [Functional Concept]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "to DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.18: Of these, ATM has been shown to be activated primarily by agents that cause DNA double-stranded breaks such as ionizing radiation (IR) or bleomycin (3). 

Phrase: "Of these,"

Phrase: "ATM"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "primarily by agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0450442:Agent [Chemical Viewed Functionally]
   756   C1254351:Agent [Pharmacologic Substance]
   756   C1521826:Agent [Intellectual Product]

Phrase: "that"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "DNA double-stranded breaks such as ionizing radiation (IR)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   815   C1511667:DNA Breaks, Double-Stranded [Cell or Molecular Dysfunction]
   767   C1721104:DNA Breaks [Molecular Function]
   758   C0872150:DNA Strand Break [Cell or Molecular Dysfunction]
   735   C0301647:Strand breaks [Molecular Function]
   711   C1881704:BREAK [Phenomenon or Process]

Phrase: "or"

Phrase: "bleomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005740:Bleomycin [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.19: In contrast, like Mec1 and Rad3, ATR is responsible for signaling the presence of multiple types of DNA damage, including those induced by ultraviolet (UV) radiation, methyl methanesulfonate, IR, and inhibitors of DNA replication (5). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "like Mec1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332120:MEC1 [Gene or Genome]

Phrase: "and"

Phrase: "Rad3,"

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "is"

Phrase: "responsible for signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "the presence of multiple types of DNA damage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "those"

Phrase: "induced by ultraviolet (UV) radiation,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0041625:Ultraviolet radiation [Natural Phenomenon or Process]
   770   C0034519:Radiation [Natural Phenomenon or Process]
   770   C0205263:Induced [Functional Concept]
   770   C0560559:Radiation [Quantitative Concept]
   770   C0851346:Radiation [Natural Phenomenon or Process]
   770   C1522449:Radiation [Therapeutic or Preventive Procedure]
   770   C1524020:Radiation [Therapeutic or Preventive Procedure]
   770   C1524021:Radiation [Research Activity]
   770   C1532472:Ultraviolet [Qualitative Concept]

Phrase: "methyl methanesulfonate,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025706:Methyl Methanesulfonate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   861   C0025619:methane sulfonate [Organic Chemical]
   861   C0066087:methane sulfonate [Organic Chemical]
   805 E C3645051:mesylate [Organic Chemical]

Phrase: "IR,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0034538:Ionising radiation [Natural Phenomenon or Process]
   861   C0034519:Radiation [Natural Phenomenon or Process]
   861   C0560559:Radiation [Quantitative Concept]
   861   C0851346:Radiation [Natural Phenomenon or Process]
   861   C1522449:Radiation [Therapeutic or Preventive Procedure]
   861   C1524020:Radiation [Therapeutic or Preventive Procedure]
   861   C1524021:Radiation [Research Activity]

Phrase: "and"

Phrase: "inhibitors of DNA replication"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   865   C1325319:DNA replication inhibitor [Molecular Function]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.20: It has been proposed that the ability of ATR to respond to such a diverse array of lesions may be due to the stalling of replication forks and subsequent generation of a common intermediate (6, 7). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that"

Phrase: "the ability of ATR to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "respond to such"

Phrase: "a diverse array of lesions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510941:Array [Spatial Concept]

Phrase: "may"

Phrase: "be due to the stalling of replication forks"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   782   C1326315:replication fork stalling [Genetic Function]
   770   C0678226:Due to [Functional Concept]
           due
   744   C0491931:forks [Medical Device]
   744   C0546910:forks [Manufactured Object]
   744   C0598312:Replication [Genetic Function]
   744   C1883725:replication [Qualitative Concept]
   744   C2987476:Be [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]

Phrase: "and"

Phrase: "subsequent generation of a common intermediate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.21: Knowledge of the manner in which ATR binds to DNA could improve our understanding of the mechanism by which DNA damage is sensed and checkpoint signaling is initiated. 

Phrase: "Knowledge of the manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0376554:Knowledge [Intellectual Product]

Phrase: "in which ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "binds to DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "could"

Phrase: "improve"

Phrase: "our understanding of the mechanism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162340:Understanding [Mental Process]

Phrase: "by which DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "is"

Phrase: "sensed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0036658:sense [Organ or Tissue Function]

Phrase: "and"

Phrase: "checkpoint signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "is"

Phrase: "initiated."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]
Processing 00000000.tx.22: Previous studies investigating the DNA binding preference of the PIK-related kinase family members in vitro have revealed both direct and indirect DNA binding modes. 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "investigating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigating [Functional Concept]

Phrase: "the DNA binding preference of the PIK-related kinase family members"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0558295:preference [Idea or Concept]
   736   C1549513:Preference [Idea or Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "have"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "both direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "indirect DNA binding modes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C1513371:Mode [Functional Concept]
   779   C1705738:Mode [Quantitative Concept]
   779   C2347637:Mode [Quantitative Concept]
   779   C2348146:Mode [Quantitative Concept]
Processing 00000000.tx.23: DNA-PK, which exists as a holoenzyme consisting of the catalytic subunit (DNA-PKcs) and the heterodimeric subunit Ku (Ku70 and Ku86), preferentially binds and is activated by double-stranded DNA ends under physiological conditions (4). 

Phrase: "DNA-PK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0212694:dna pk [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "exists as a holoenzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2987476:Exist [Conceptual Entity]

Phrase: "consisting of the catalytic subunit"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0600499:Catalytic Subunit [Amino Acid Sequence]
   760   C0007382:Catalytic [Natural Phenomenon or Process]
   760   C1711351:Subunit [Quantitative Concept]
   726   C0332529:CONSIST [Qualitative Concept]

Phrase: "(DNA-PKcs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1335262:DNA-PKcs [Gene or Genome]
  1000   C3536788:DNA-PKcs [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0657318:PKCS [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "and"

Phrase: "the heterodimeric subunit Ku"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1532717:ku [Quantitative Concept]
   827   C1881335:kU [Quantitative Concept]

Phrase: "(Ku70"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705873:Ku70 [Gene or Genome]
  1000   C1823878:Ku70 [Gene or Genome]

Phrase: "and"

Phrase: "Ku86"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1337034:Ku86 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "preferentially"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "is"

Phrase: "activated by double-stranded DNA"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1979882:Double strand [Qualitative Concept]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205173:Double [Functional Concept]
   760   C1705764:Double [Activity]
   760   C1705765:Double [Qualitative Concept]
   760   C1879547:Activated [Activity]
   726 E C1515877:Activate [Functional Concept]

Phrase: "ends under physiological conditions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205463:Physiological [Functional Concept]
   770   C0444930:End [Spatial Concept]
   770   C2746065:End [Temporal Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.24: This binding and activation requires the Ku subunits. 

Phrase: "This binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "requires"

Phrase: "the Ku subunits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.25: Under low salt conditions, however, DNA-PKcs alone can bind and be activated by both single- and double-stranded DNA ends (ssDNA and dsDNA) in the absence of Ku (8, 9). 

Phrase: "Under low salt conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "however,"

Phrase: "DNA-PKcs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1335262:DNA-PKcs [Gene or Genome]
  1000   C3536788:DNA-PKcs [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0657318:PKCS [Amino Acid, Peptide, or Protein]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "can"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "be"

Phrase: "activated by both single-"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0037179:Single [Population Group]
   770   C0087136:single [Finding]
   770   C0205171:Single [Quantitative Concept]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "double-stranded DNA ends"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   812   C0444930:ends [Spatial Concept]
   779 E C2746065:End [Temporal Concept]
   756   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   741 E C0205088:Terminal [Temporal Concept]
   741 E C1705314:Terminal [Manufactured Object]
   741 E C1705315:Terminal [Spatial Concept]

Phrase: "(ssDNA"

Phrase: "and"

Phrase: "dsDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0311474:ds-DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of Ku"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1532717:ku [Quantitative Concept]
  1000   C1881335:kU [Quantitative Concept]

Phrase: "(8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.26: Similar to DNA-PK, ATM prefers to bind dsDNA ends in vitro (10, 11). 

Phrase: "Similar to DNA-PK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "ATM"

Phrase: "prefers"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "dsDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0311474:ds-DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "ends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(10,"

Phrase: "11"

Phrase: ")."
Processing 00000000.tx.27: Unlike DNA-PK, however, purified ATM retains its ability to bind DNA in vitro, suggesting it does not require an additional factor for DNA binding (10). 

Phrase: "Unlike DNA-PK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0212694:dna pk [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "however,"

Phrase: "purified ATM"

Phrase: "retains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "it"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "an additional factor for DNA binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.28: The manner in which ATR binds to and is activated by damaged DNA is unclear. 

Phrase: "The manner in which ATR"

Phrase: "binds to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1145667:Bind [Activity]
   833   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "is"

Phrase: "activated by damaged DNA"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   816   C0012860:damage dna [Cell or Molecular Dysfunction]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1879547:Activated [Activity]
   737   C0010957:Damage [Injury or Poisoning]
   737 E C1515877:Activate [Functional Concept]
   737   C1883709:Damage [Functional Concept]

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.29: Xenopus ATR (XATR) (12) and human ATR (13) have been shown to bind chromatin, and other studies indicate that human ATR can bind ssDNA after partial purification (14). 

Phrase: "Xenopus ATR (XATR) (12"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0043342:Xenopus [Amphibian]
   827   C0043343:Xenopus [Amphibian]
   827   C1504663:Xenopus [Amphibian]
   827   C3540546:ATR [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "human ATR (13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0086418:Human [Human]
   827   C3540546:ATR [Gene or Genome]

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "chromatin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
  1000   C1325550:chromatin [Cell Component]

Phrase: "and"

Phrase: "other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that human ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540546:ATR [Gene or Genome]

Phrase: "can"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "ssDNA after partial purification"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.30: Recombinant, purified, FLAG-tagged ATR (FATR) has also been shown to weakly bind UV-damaged DNA in vitro (15). 

Phrase: "Recombinant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514798:recombinant [Organism]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: ","

Phrase: "FLAG-tagged ATR (FATR)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540546:ATR [Gene or Genome]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to weakly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "UV-damaged DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0012860:damage dna [Cell or Molecular Dysfunction]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.31: In the yeasts, the ATR-related kinases Rad3 and Mec1 are found in higher order complexes with the checkpoint proteins Rad26 and Lcd1/Ddc2, respectively (2). 

Phrase: "In the yeasts,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0043393:Yeasts [Fungus]
   966 E C0036025:yeast [Fungus]
   966 E C0043392:Yeast [Food]
   966 E C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "the ATR-related kinases Rad3"

Phrase: "and"

Phrase: "Mec1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332120:MEC1 [Gene or Genome]

Phrase: "are"

Phrase: "found in higher order complexes"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   760   C0150312:Found [Quantitative Concept]
   760   C1704241:Complexes [Chemical Viewed Structurally]
   760   C1705175:Order [Intellectual Product]
   760   C1705176:Order [Qualitative Concept]
   760   C1705177:Order [Classification]
   760   C1705178:Order [Activity]
   760   C1882348:Order [Qualitative Concept]
   726   C0205250:High [Qualitative Concept]
   726 E C0243095:Find [Finding]
   726 E C0439855:Complex [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "with the checkpoint proteins Rad26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1366757:RAD26 [Gene or Genome]

Phrase: "and"

Phrase: "Lcd1/Ddc2,"

Phrase: "respectively"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.32: S. pombe Rad26 undergoes Rad3-dependent phosphorylation in response to checkpoint activation by either DNA damaging agents or replication inhibitors, and this phosphorylation occurs in the absence of Rad1, Rad9, Hus1, and Rad17, all of which are necessary for downstream signaling (16). 

Phrase: "S. pombe Rad26"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1366757:RAD26 [Gene or Genome]
   734   C0178453:S pombe [Fungus]

Phrase: "undergoes"

Phrase: "Rad3-dependent phosphorylation in response to checkpoint activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "by either DNA damaging agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0450442:Agent [Chemical Viewed Functionally]
   779   C1254351:Agent [Pharmacologic Substance]
   779   C1521826:Agent [Intellectual Product]

Phrase: "or"

Phrase: "replication inhibitors,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "this phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "occurs in the absence of Rad1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]

Phrase: "Rad9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419245:RAD9 [Gene or Genome]

Phrase: "Hus1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415818:HUS1 [Gene or Genome]

Phrase: "and"

Phrase: "Rad17,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419232:RAD17 [Gene or Genome]

Phrase: "all of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: "are"

Phrase: "necessary for downstream signaling"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.33: A recent study using GFP-tagged Rad26 showed that Rad26 can localize to sites of damage in the absence of these other checkpoint proteins or the checkpoint kinase Rad3 (17). 

Phrase: "A recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GFP-tagged Rad26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1366757:RAD26 [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Rad26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366757:RAD26 [Gene or Genome]

Phrase: "can"

Phrase: "localize to sites of damage"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C2945843:Site of [Qualitative Concept]
   760   C0010957:Damage [Injury or Poisoning]
   760   C0205145:Sites [Spatial Concept]
   760   C0392752:localize [Spatial Concept]
   760   C1883709:Damage [Functional Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of these"

Phrase: "other checkpoint proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "the checkpoint kinase Rad3"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.34: Similar to Rad26, the S. cerevisiae homolog Lcd1 is phosphorylated by Mec1 in the absence of other known checkpoint proteins (1820). 

Phrase: "Similar to Rad26,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "the S. cerevisiae homolog Lcd1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1690006:LCD1 [Disease or Syndrome]
   812   C1704975:LCD1 [Gene or Genome]

Phrase: "is"

Phrase: "phosphorylated by Mec1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1332120:MEC1 [Gene or Genome]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of other known checkpoint proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1820"

Phrase: ")."
Processing 00000000.tx.35: In vitro, purified, recombinant Lcd1 binds to single- and double-stranded DNA oligonucleotides and is necessary for Mec1 to bind DNA (21). 

Phrase: "In vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: ","

Phrase: "recombinant Lcd1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1690006:LCD1 [Disease or Syndrome]
   861   C1704975:LCD1 [Gene or Genome]

Phrase: "binds to single-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0037179:Single [Population Group]
   790   C0087136:single [Finding]
   790   C0205171:Single [Quantitative Concept]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "double-stranded DNA oligonucleotides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "is"

Phrase: "necessary for Mec1 to"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.36: In addition, ChIP analyses have shown a requirement for Lcd1 in the recruitment of Mec1 to HO endonuclease-induced double-stranded breaks as well as cdc131-induced lesions, suggesting Lcd1 is required in vivo (21). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "ChIP analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a requirement for Lcd1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514873:Requirement [Functional Concept]

Phrase: "in the recruitment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2949735:Recruitment [Activity]

Phrase: "of Mec1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332120:MEC1 [Gene or Genome]

Phrase: "to HO endonuclease-induced double-stranded breaks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0301647:Strand breaks [Molecular Function]
   766   C1881704:BREAK [Phenomenon or Process]

Phrase: "as well as"

Phrase: "cdc131-induced lesions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0221198:lesions [Finding]
   793 E C1546698:Lesion [Intellectual Product]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "Lcd1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1690006:LCD1 [Disease or Syndrome]
  1000   C1704975:LCD1 [Gene or Genome]

Phrase: "is"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.37: However, in contrast to Rad3-independent Rad26 damage-induced foci formation, another study has shown that Mec1 is required for the formation of Lcd1 foci at HO endonuclease-induced breaks (22). 

Phrase: "However,"

Phrase: "in contrast to Rad3-independent Rad26 damage-induced foci formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0220781:formation [Biologic Function]
   795   C0439634:formation [Spatial Concept]
   795   C1522492:Formation [Functional Concept]

Phrase: "another study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Mec1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332120:MEC1 [Gene or Genome]

Phrase: "is"

Phrase: "required for the formation of Lcd1 foci"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0205234:Foci [Spatial Concept]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1514873:Required [Functional Concept]
   748   C1522492:Formation [Functional Concept]
   748   C1690006:LCD1 [Disease or Syndrome]
   748   C1704975:LCD1 [Gene or Genome]
   714 E C1285542:focus [Functional Concept]

Phrase: "at HO endonuclease-induced breaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1881704:BREAK [Phenomenon or Process]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.38: Recently, the putative human homolog of Rad26 and Lcd1, ATRIP (ATR-interacting protein) was identified, and like ATR, its function is required for the cellular response to DNA damage and replication stress (23). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "the putative human homolog of Rad26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1334043:Homolog [Gene or Genome]

Phrase: "and"

Phrase: "Lcd1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1690006:LCD1 [Disease or Syndrome]
  1000   C1704975:LCD1 [Gene or Genome]

Phrase: "ATRIP"

Phrase: "(ATR-interacting protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0967200:ATR-Interacting Protein [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2243119:ATR-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "was"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "and like ATR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515981:And [Idea or Concept]
   790   C3540546:ATR [Gene or Genome]

Phrase: "its function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "required for the cellular response"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C2985857:Required Response [Idea or Concept]
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0871261:Response [Organism Attribute]
   760   C1514873:Required [Functional Concept]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "to DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "replication stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.39: Similar to its homologs in yeast, ATRIP is phosphorylated by ATR and colocalizes with ATR in cells treated with DNA damaging agents. 

Phrase: "Similar to its homologs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "in yeast,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036025:yeast [Fungus]
  1000   C0043392:Yeast [Food]
  1000   C0043393:Yeast [Fungus]
  1000   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "ATRIP"

Phrase: "is"

Phrase: "phosphorylated by ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "colocalizes with ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3540546:ATR [Gene or Genome]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with DNA damaging agents."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1522326:Treated [Functional Concept]
   726   C0450442:Agent [Chemical Viewed Functionally]
   726   C1254351:Agent [Pharmacologic Substance]
   726 E C1292734:TREAT [Functional Concept]
   726   C1521826:Agent [Intellectual Product]
Processing 00000000.tx.40: Recent studies have shown that the single-stranded DNA binding protein RPA (replication protein A) is necessary for the in vitro binding of ATRIP to DNA and that loss of RPA prevents the formation of ATR and ATRIP foci in mammalian cells treated with ionizing radiation (24). 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the single-stranded DNA binding protein RPA"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   878   C1413746:DNA-BINDING PROTEIN A [Gene or Genome]
   836   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   836   C0598312:DNA Replication [Genetic Function]
           Replication
   836   C2984261:DNA replication [Functional Concept]
   835   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   835   C1167121:replication protein A [Cell Component]
   793   C1883725:replication [Qualitative Concept]
   723   C0037183:Single-Stranded DNA-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   723   C3537332:Single-Stranded DNA-Binding Protein [Amino Acid, Peptide, or Protein]
   721 E C0205173:Replicate [Functional Concept]
   721 E C0205341:Replicate [Functional Concept]

Phrase: "(replication protein A"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]

Phrase: ")"

Phrase: "is"

Phrase: "necessary for the in vitro binding of ATRIP"

Phrase: "to DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "that loss of RPA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the formation of ATR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "ATRIP foci in mammalian cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0205234:Foci [Spatial Concept]
   726 E C1285542:focus [Functional Concept]

Phrase: "treated with ionizing radiation"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C0034538:Ionising radiation [Natural Phenomenon or Process]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0034519:Radiation [Natural Phenomenon or Process]
   770   C0560559:Radiation [Quantitative Concept]
   770   C0851346:Radiation [Natural Phenomenon or Process]
   770   C1522326:Treated [Functional Concept]
   770   C1522449:Radiation [Therapeutic or Preventive Procedure]
   770   C1524020:Radiation [Therapeutic or Preventive Procedure]
   770   C1524021:Radiation [Research Activity]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.41: The ATR kinase activity has also been shown to affect ATR and RPA translocation following ionizing radiation, suggesting that ATR may be necessary for RPA binding to damaged DNA (25). 

Phrase: "The ATR kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "RPA translocation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0599893:Protein translocation [Cell Function]
   812   C0040715:Translocation [Cell or Molecular Dysfunction]
   812   C2987521:Translocation [Activity]
   756   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1167121:replication protein A [Cell Component]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "ionizing radiation,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0034538:Ionising radiation [Natural Phenomenon or Process]
   861   C0034519:Radiation [Natural Phenomenon or Process]
   861   C0560559:Radiation [Quantitative Concept]
   861   C0851346:Radiation [Natural Phenomenon or Process]
   861   C1522449:Radiation [Therapeutic or Preventive Procedure]
   861   C1524020:Radiation [Therapeutic or Preventive Procedure]
   861   C1524021:Radiation [Research Activity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "may"

Phrase: "be"

Phrase: "necessary for RPA binding"

Phrase: "to damaged DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0012860:damage dna [Cell or Molecular Dysfunction]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.42: We have developed an in vitro DNA binding assay to study the interaction of ATR and ATRIP with DNA. 

Phrase: "We"

Phrase: "have"

Phrase: "developed"

Phrase: "an in vitro DNA binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1148673:DNA Binding [Genetic Function]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the interaction of ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "ATRIP with DNA."
Processing 00000000.tx.43: Using this assay, we show that ATR and ATRIP exist in a large molecular weight complex that is able to bind DNA after significant purification. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "exist in a large molecular weight complex"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0026385:Molecular Weight [Quantitative Concept]
   748   C0005910:weight [Organism Attribute]
   748   C0043100:Weight [Quantitative Concept]
   748   C0439855:Complex [Qualitative Concept]
   748   C0549177:Large [Quantitative Concept]
   748   C1305866:weight [Diagnostic Procedure]
   748   C1521991:Molecular [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]
   748   C1705104:Weight [Idea or Concept]
   748   C2987476:Exist [Conceptual Entity]

Phrase: "that"

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA after significant purification."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0872148:DNA purification [Laboratory Procedure]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.44: Interestingly, this ATR-ATRIP complex can bind ssDNA in the absence of RPA; 

Phrase: "Interestingly,"

Phrase: "this ATR-ATRIP complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2611008:ATR-ATRIP complex [Cell Component]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "can"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "ssDNA in the absence of RPA"

Phrase: ";"
Processing 00000000.tx.45: although, as previously reported, we also find that RPA is necessary for the binding of a distinct ATR-ATRIP complex to DNA at higher salt concentrations (24). 

Phrase: "although"

Phrase: ","

Phrase: "as"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: ","

Phrase: "we also"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that RPA"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]

Phrase: "is"

Phrase: "necessary for the binding of a distinct ATR-ATRIP complex"

Phrase: "to DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "at higher salt concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.46: We have further characterized the lower affinity, RPA-independent mode of binding and found that purified ATR and ATRIP are unable to bind DNA either alone or together. 

Phrase: "We"

Phrase: "have"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "the lower affinity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "RPA-independent mode of binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1513371:Mode [Functional Concept]
   748   C1705738:Mode [Quantitative Concept]
   748   C2347637:Mode [Quantitative Concept]
   748   C2348146:Mode [Quantitative Concept]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that purified ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "are"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "either alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "together."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]
Processing 00000000.tx.47: This finding indicates that an additional as of yet unidentified protein is required for the in vitro DNA binding of this ATR-ATRIP complex. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "indicates"

Phrase: "that"

Phrase: "an additional as of yet unidentified protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1524062:Additional [Functional Concept]

Phrase: "is"

Phrase: "required for the in vitro DNA binding of this ATR-ATRIP complex."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C2611008:ATR-ATRIP complex [Cell Component]
   753   C0021135:In Vitro [Intellectual Product]
   753   C1148673:DNA Binding [Genetic Function]
   753   C1533691:in vitro [Qualitative Concept]
           vitro
   753   C2827718:In Vitro [Functional Concept]
   736   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0243122:binding [Functional Concept]
   736   C0439855:Complex [Qualitative Concept]
   736   C1145667:Binding [Activity]
   736   C1167622:Binding [Molecular Function]
   736   C1514873:Required [Functional Concept]
   736   C1704241:Complex [Chemical Viewed Structurally]
   736   C3540546:ATR [Gene or Genome]
Processing 00000000.tx.48: Our data also indicate that ATR is necessary for the interaction of ATRIP with DNA in this RPA-independent mode. 

Phrase: "Our data also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "is"

Phrase: "necessary for the interaction of ATRIP"

Phrase: "with DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in this RPA-independent mode."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C1513371:Mode [Functional Concept]
   804   C1705738:Mode [Quantitative Concept]
   804   C2347637:Mode [Quantitative Concept]
   804   C2348146:Mode [Quantitative Concept]
   717   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1167121:replication protein A [Cell Component]
Processing 00000000.tx.49: Together, these results suggest that there are two distinct modes for the interaction of the ATR-ATRIP complex with DNA in vitro, one that is RPA-dependent and one that is RPA-independent but requires an unknown protein activity.  

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "are"

Phrase: "two distinct modes for the interaction of the ATR-ATRIP complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   704   C1513371:Mode [Functional Concept]
   704   C1705738:Mode [Quantitative Concept]
   704   C2347637:Mode [Quantitative Concept]
   704   C2348146:Mode [Quantitative Concept]

Phrase: "with DNA in vitro, one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205447:One [Quantitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "RPA-dependent"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0851827:Dependent [Qualitative Concept]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]
   756   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1167121:replication protein A [Cell Component]

Phrase: "and"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "RPA-independent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0085862:Independent [Idea or Concept]
   812   C1299583:Independent [Finding]
   756   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1167121:replication protein A [Cell Component]

Phrase: "but"

Phrase: "requires"

Phrase: "an unknown protein activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1537044:protein activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.50: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Cell Lines and AntibodiesHuman embryonic kidney (HEK) 293T cells were maintained in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell Lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "AntibodiesHuman embryonic kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0022646:Kidney [Body Part, Organ, or Organ Component]
   827   C0227665:kidney [Body Part, Organ, or Organ Component]
   827   C1278978:Kidney [Body Part, Organ, or Organ Component]
   827   C1514845:KIDNEY [Tissue]
   734 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "(HEK) 293T cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained in Dulbecco's modified Eagle's medium"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagle [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1314677:Maintained [Functional Concept]
   753   C1551720:Eagle [Population Group]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719 E C0024501:Maintain [Activity]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "supplemented with 10% fetal bovine serum."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.51: HeLa cell pellets were purchased from the National Cell Culture Center. 

Phrase: "HeLa cell pellets"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0993610:pellets [Biomedical or Dental Material]
   793 E C0441436:Pellet [Manufactured Object]
   793 E C1998480:Pellet [Quantitative Concept]
   734   C0018873:HeLa cell [Cell]

Phrase: "were"

Phrase: "purchased from the National Cell Culture Center."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0007585:Cell Culture [Laboratory Procedure]
   748   C0007634:Cell [Cell]
   748   C0010453:Culture [Idea or Concept]
   748   C0205099:Center [Spatial Concept]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0869011:purchased [Activity]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2242979:Culture [Laboratory Procedure]
   748   C3245503:national [Intellectual Product]
Processing 00000000.tx.52: The FLAG M5 antibody and M2-agarose affinity gel (Sigma), Myc 9E10 antibody (Santa Cruz), human ORC2 antibody (BD Bioscience), and human RPA AB3 antibody (Oncogene) were purchased from commercial sources. 

Phrase: "The FLAG M5 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "M2-agarose affinity gel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1706746:Agarose Gel [Research Device]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C1382104:Gel [Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "Myc 9E10 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Santa Cruz"

Phrase: ")"

Phrase: ","

Phrase: "human ORC2 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(BD Bioscience"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "human RPA AB3 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Oncogene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "purchased from commercial sources."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1516719:Commercial Sources [Classification]
   770   C0449416:sources [Finding]
   770   C0680536:commercial [Intellectual Product]
   770   C0869011:purchased [Activity]
   770   C3272563:Commercial [Intellectual Product]
   737 E C1705919:Source [Idea or Concept]
Processing 00000000.tx.53: The antibody to insulin degrading enzyme (IDE) was a gift from Dr. 

Phrase: "The antibody to insulin degrading enzyme (IDE)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0021644:Insulin antibody [Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "a gift from Dr."
Processing 00000000.tx.54: Richard Roth. 

Phrase: "Richard Roth."
Processing 00000000.tx.55: The human ATR antibody was described previously (5). 

Phrase: "The human ATR antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.56: Anti-human ATRIP antibody used for immunodepletion was generated at a commercial facility (Josman, Napa, CA) using GST-ATRIP 1107 as described (23), and the ATRIP antibody used for Western blotting was a gift of Dr. 

Phrase: "Anti-human ATRIP antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used for immunodepletion"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "generated at a commercial facility"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0680536:commercial [Intellectual Product]
   760   C1547538:Facility [Idea or Concept]
   760   C3146294:Generated [Activity]
   760   C3272563:Commercial [Intellectual Product]

Phrase: "(Josman,"

Phrase: "Napa,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417599:NAPA [Gene or Genome]
  1000   C1538038:NAPA [Gene or Genome]

Phrase: "CA)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GST-ATRIP 1107"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the ATRIP antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used for Western blotting"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1273517:used [Finding]
   770   C1705493:Western [Spatial Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "a gift of Dr."
Processing 00000000.tx.57: Stephen Elledge. 

Phrase: "Stephen Elledge."
Processing 00000000.tx.58: Extract PreparationTo prepare whole cell extracts, cells were harvested by trypsinization, washed in phosphate-buffered saline, resuspended in modified TGN buffer (50 mM Tris pH 7.5, 150 mM NaCl, 50 mM -glycerophosphate, 10% glycerol, 1% Tween 20, 0.2% Nonidet P-40, and 1 mM NaF, Na3VO4, PMSF, DTT, leupeptin, pepstatin, and aprotinin) and cleared by centrifugation (10 min, 16,000 x g). 

Phrase: "Extract PreparationTo"

Phrase: "prepare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521827:Prepare [Functional Concept]

Phrase: "whole cell extracts,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0007592:Cell Extracts [Cell Component]
   793   C2828366:Extract [Substance]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested by trypsinization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1512335:Harvest [Health Care Activity]

Phrase: "washed in phosphate-buffered saline,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1548982:Washed [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0441648:Wash [Activity]

Phrase: "resuspended in modified TGN buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0392747:Modified [Functional Concept]
   760   C0887838:TGN [Cell Component]
   760   C1420709:TGN [Gene or Genome]

Phrase: "(50 mM Tris pH 7.5,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C1882074:pH 7 [Qualitative Concept]
   799   C0020283:[pH] [Quantitative Concept]
   799   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   799   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]
   799   C0814229:TRI [Intellectual Product]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "50 mM -glycerophosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "1% Tween 20,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   873 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   827   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]
   771 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "0.2% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: "and"

Phrase: "1 mM NaF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   827   C1366571:NAF [Gene or Genome]
   827   C1705592:NAF [Gene or Genome]

Phrase: "Na3VO4,"

Phrase: "PMSF,"

Phrase: "DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "pepstatin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "aprotinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "cleared by centrifugation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0521097:Cleared by [Functional Concept]
           cleared
   790   C0007703:Centrifugation [Laboratory Procedure]
   756 E C2963144:Clear [Qualitative Concept]

Phrase: "(10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "16,000 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.59: Nuclear extracts were prepared as described (26) and dialyzed into Buffer D (20 mM Hepes-KOH pH 7.9, 0.2 mM EDTA, 20% glycerol, 1 mM DTT, and 1 mM PMSF) containing 100 mM KCl (D100). 

Phrase: "Nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared as described"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552738:described [Idea or Concept]
   756   C1521827:Prepare [Functional Concept]

Phrase: "(26"

Phrase: ")"

Phrase: "and"

Phrase: "dialyzed into Buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "D ("

Phrase: "20 mM Hepes-KOH pH 7.9,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   818   C1882074:pH 7 [Qualitative Concept]
   795   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   795   C0020283:[pH] [Quantitative Concept]
   795   C0071767:KOH [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]

Phrase: "0.2 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "20% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "1 mM PMSF"

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100 mM KCl"

Phrase: "(D100"

Phrase: ")."
Processing 00000000.tx.60: Subcellular Fractionation and PurificationSubcellular fractionations were performed as described (27) with slight modification. 

Phrase: "Subcellular Fractionation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1656251:subcellular fractionation [Laboratory Procedure]
   861   C0016640:fractionation [Laboratory Procedure]
   861   C0524811:fractionation [Therapeutic or Preventive Procedure]
   861   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "PurificationSubcellular fractionations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016640:fractionation [Laboratory Procedure]
   827   C0524811:fractionation [Therapeutic or Preventive Procedure]
   827   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "performed as described"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(27"

Phrase: ")"

Phrase: "with slight modification."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392747:Modification [Functional Concept]
   861   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.61: For micrococcal nuclease digestion, nuclei from 5 x 106 293T cells were washed and resuspended in 200 l of buffer A (10 mM HEPES pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, 1 mM DTT, 10 mM NaF, 1 mM Na2VO3, protease inhibitors) with 1 mM CaCl2 then digested with 1 unit of micrococcal nuclease (Sigma) and incubated for 2 min at 37 C. 

Phrase: "For micrococcal nuclease digestion,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0012238:Digestion [Organism Function]
   827   C2349986:Digestion [Research Activity]
   771 E C0443277:Peptic [Functional Concept]
   734   C0025965:Micrococcal Nuclease [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "nuclei from 5 x 106 293T cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0007610:Cell Nuclei [Cell Component]
           Nucleus
   757   C3496275:nucleus X [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "resuspended in 200 l"

Phrase: "of buffer A (10 mM HEPES pH 7.9,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C1882074:pH 7 [Qualitative Concept]
   793   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   793   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   793   C0020283:[pH] [Quantitative Concept]
   793   C0450407:ph+ [Finding]
   793   C0450408:ph++ [Finding]
   793   C0450409:ph+++ [Finding]

Phrase: "10 mM KCl,"

Phrase: "1.5 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.34 M sucrose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "10 mM NaF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   827   C1366571:NAF [Gene or Genome]
   827   C1705592:NAF [Gene or Genome]

Phrase: "1 mM Na2VO3,"

Phrase: "protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "with 1 mM CaCl2 then"

Phrase: "digested with 1 unit of micrococcal nuclease"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0025965:Micrococcal Nuclease [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0439148:Unit [Quantitative Concept]
   748   C0597094:nuclease [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0868946:digested [Physiologic Function]
   748   C1519795:Unit [Quantitative Concept]
   748   C1704753:Unit [Manufactured Object]
   748   C1880519:Unit [Quantitative Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "incubated for 2 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37 C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]
Processing 00000000.tx.62: The reaction was stopped with 1 mM EGTA. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped with 1 mM EGTA."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   797   C1418486:MM-1 [Gene or Genome]
   760   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1272691:stopped [Qualitative Concept]
   726 E C1947925:Stop [Activity]
   726 E C2746065:Stop [Temporal Concept]
Processing 00000000.tx.63: For sucrose gradients, extracts were layered over a 530% sucrose gradient in 20 mM HEPES pH 7.4 and centrifuged at 55,000 rpm for 3 h in a TLS-55 rotor (Beckman). 

Phrase: "For sucrose gradients,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0812409:gradients [Quantitative Concept]
   827 E C0439182:% gradient [Quantitative Concept]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "layered over a 530% sucrose gradient"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0439182:% gradient [Quantitative Concept]
   753   C0812409:Gradient [Quantitative Concept]
   753   C0934502:Layered [Body Part, Organ, or Organ Component]
   753   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   719 E C1522408:Layer [Qualitative Concept]
   719 E C1561599:Layer [Intellectual Product]

Phrase: "in 20 mM HEPES pH 7.4"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   839   C2678549:PH-4 [Gene or Genome]
   827   C1882074:pH 7 [Qualitative Concept]
   799   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C0020283:[pH] [Quantitative Concept]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "centrifuged at 55,000 rpm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0450382:55 [Intellectual Product]
   760   C0582523:rpm [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 3 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:3 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in a TLS-55 rotor"

Phrase: "(Beckman"

Phrase: ")."
Processing 00000000.tx.64: Sizing markers -amylase (200 kDa) and thyroglobulin (670 kDa) (Sigma) were run in parallel. 

Phrase: "Sizing markers -amylase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002712:Amylase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(200 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "thyroglobulin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0040123:Thyroglobulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1527123:Thyroglobulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   944 E C3642448:Proloid [Pharmacologic Substance]

Phrase: "(670 kDa) (Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "run in parallel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C2348042:Parallel [Qualitative Concept]
   827   C2826345:PARALLEL [Research Activity]
   734   C3274438:RUN-IN [Temporal Concept]
Processing 00000000.tx.65: Partial purification of the ATR-ATRIP complex was carried out using Amersham Biosciences resins, columns and an AKTA explorer FPLC. 

Phrase: "Partial purification of the ATR-ATRIP complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243114:purification [Functional Concept]
   748   C1998793:Purification [Functional Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Amersham Biosciences resins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035191:resins [Biomedical or Dental Material]

Phrase: "columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1185738:Column [Body Part, Organ, or Organ Component]
   966   C1706132:Column [Idea or Concept]

Phrase: "and"

Phrase: "an AKTA explorer FPLC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0599209:FPLC [Laboratory Procedure]
Processing 00000000.tx.66: HeLa nuclear extract (25 mg) was precipitated with addition of solid NH2SO4 to 40% w/v on ice over 30 min with stirring followed by centrifugation at 16000 x g for 30 min at 4 C. 

Phrase: "HeLa nuclear extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1518434:Nuclear Extract [Biomedical or Dental Material]
   827   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "(25 mg)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "was"

Phrase: "precipitated with addition of solid NH2SO4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205208:Solid [Qualitative Concept]
   753   C0302909:Solid [Substance]
   753   C1378566:Solid [Biomedical or Dental Material]
   753   C1883712:Addition [Functional Concept]
   719   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "to 40% w/v"

Phrase: "on ice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020746:Ice [Inorganic Chemical]

Phrase: "over 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "with stirring"

Phrase: "followed by centrifugation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0007703:Centrifugation [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "at 16000 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]
Processing 00000000.tx.67: The pellet was resuspended in half the original volume with buffer E (20 mM Hepes-NaOH pH 7.9, 1 mM EDTA, 10% glycerol, 1 mM DTT, and 1 mM PMSF) containing 150 mM NaCl (E150), incubated on ice for 30 min and centrifuged at 16000 x g for 30 min at 4 C. 

Phrase: "The pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "resuspended in half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2825407:Half [Quantitative Concept]

Phrase: "the original volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "with buffer E (20 mM Hepes-NaOH pH 7.9,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   807   C1882074:pH 7 [Qualitative Concept]
   791   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   791   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   791   C0020283:[pH] [Quantitative Concept]
   791   C0450407:ph+ [Finding]
   791   C0450408:ph++ [Finding]
   791   C0450409:ph+++ [Finding]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "1 mM PMSF"

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "150 mM NaCl (E150"

Phrase: ")"

Phrase: ","

Phrase: "incubated on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "centrifuged at 16000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]
Processing 00000000.tx.68: The supernatant (2 ml) was applied to a S-300 column equilibrated in E150. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "(2 ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "applied to a S-300 column"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0185125:Applied [Health Care Activity]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
   719 E C1632850:Apply [Functional Concept]
   719 E C1879355:Apply [Functional Concept]

Phrase: "equilibrated in E150."
Processing 00000000.tx.69: Fractions containing ATR-ATRIP were pooled, diluted 2-fold in buffer E with no salt (E0) and applied to a Q-Sepharose column equilibrated with buffer E containing 100 mM NaCl (E100). 

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "ATR-ATRIP"

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: ","

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "2-fold in buffer E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332462:Fold [Spatial Concept]
   760   C1880834:FOLD [Phenomenon or Process]

Phrase: "with no salt"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0036140:Salt [Chemical Viewed Structurally]
  1000   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
  1000   C0206136:Salt [Food,Inorganic Chemical]
   928 E C1537053:salty [Qualitative Concept]
   900 E C0678584:saltiness [Qualitative Concept]

Phrase: "(E0"

Phrase: ")"

Phrase: "and"

Phrase: "applied to a Q-Sepharose column"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0036681:Sepharose [Carbohydrate]
   753   C0185125:Applied [Health Care Activity]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
   719 E C1632850:Apply [Functional Concept]
   719 E C1879355:Apply [Functional Concept]

Phrase: "equilibrated with buffer E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100 mM NaCl (E100"

Phrase: ")."
Processing 00000000.tx.70: ATR and ATRIP were eluted with a 100 mM to 400 mM NaCl gradient, pooled, and applied to a heparin-Sepharose HP column equilibrated with buffer E containing 200 mM NaCl (E200). 

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "were"

Phrase: "eluted with a 100 mM"

Phrase: "to 400 mM NaCl gradient,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439182:% gradient [Quantitative Concept]
   812   C0812409:Gradient [Quantitative Concept]

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: ","

Phrase: "and"

Phrase: "applied to a heparin-Sepharose HP column"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0062515:heparin-sepharose [Carbohydrate,Pharmacologic Substance]
   748   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0036681:Sepharose [Carbohydrate]
   748   C0185125:Applied [Health Care Activity]
   748   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1706132:Column [Idea or Concept]
   714 E C1632850:Apply [Functional Concept]
   714 E C1879355:Apply [Functional Concept]

Phrase: "equilibrated with buffer E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "200 mM NaCl (E200"

Phrase: ")."
Processing 00000000.tx.71: A 200800 mM NaCl gradient was used to elute proteins from heparin. 

Phrase: "A 200800 mM NaCl gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439182:% gradient [Quantitative Concept]
   812   C0812409:Gradient [Quantitative Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elute"

Phrase: "proteins from heparin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.72: Fractions containing ATR and ATRIP were pooled and diluted 4-fold with E0, applied to ssDNA cellulose (Sigma) equilibrated with E100 and eluted with buffer E containing 400 mM NaCl. 

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: "and"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "4-fold with E0,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332462:Fold [Spatial Concept]
   770   C1880834:FOLD [Phenomenon or Process]

Phrase: "applied to ssDNA cellulose"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   770   C0185125:Applied [Health Care Activity]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "equilibrated with E100"

Phrase: "and"

Phrase: "eluted with buffer E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "400 mM NaCl."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]
Processing 00000000.tx.73: Sizing markers -amylase (200 kDa) and thyroglobulin (670 kDa) (Sigma) were used to calibrate the S-300 column. 

Phrase: "Sizing markers -amylase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0002712:Amylase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(200 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "thyroglobulin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0040123:Thyroglobulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1527123:Thyroglobulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   944 E C3642448:Proloid [Pharmacologic Substance]

Phrase: "(670 kDa) (Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calibrate"

Phrase: "the S-300 column."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]
Processing 00000000.tx.74: DNA Binding AnalysisNuclear extracts were applied to the ssDNA cellulose (Sigma) column equilibrated with buffer D containing 100 mM NaCl or 100 mM KCl as indicated. 

Phrase: "DNA Binding AnalysisNuclear extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "applied to the ssDNA cellulose"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   760   C0185125:Applied [Health Care Activity]
   726 E C1632850:Apply [Functional Concept]
   726 E C1879355:Apply [Functional Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "equilibrated with buffer D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100 mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "or"

Phrase: "100 mM KCl"

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.75: Column flow-through was re-applied once prior to washing. 

Phrase: "Column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "flow-through"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "re-applied"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0185125:Applied [Health Care Activity]
   861   C2986904:RE [Idea or Concept]
   827 E C1632850:Apply [Functional Concept]
   827 E C1879355:Apply [Functional Concept]

Phrase: "once prior to washing."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0332152:Prior to [Temporal Concept]
           Prior
   770   C0441648:Washing [Activity]
   770   C1720092:Once [Intellectual Product]
   770   C1948045:Once [Temporal Concept]
   770   C2826257:PRIOR [Event]
Processing 00000000.tx.76: Proteins were eluted with buffer D containing 400 mM salt. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "eluted with buffer D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "400 mM salt."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0036140:Salt [Chemical Viewed Structurally]
   827   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0206136:Salt [Food,Inorganic Chemical]
   755 E C1537053:salty [Qualitative Concept]
   727 E C0678584:saltiness [Qualitative Concept]
Processing 00000000.tx.77: Any protein remaining bound after this elution was eluted with 10% SDS. 

Phrase: "Any protein remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1527428:Remaining [Qualitative Concept]

Phrase: "bound after this elution"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1441565:Elution [Laboratory Procedure]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]

Phrase: "was"

Phrase: "eluted with 10% SDS."
Processing 00000000.tx.78: DNA binding experiments with purified proteins in Fig. 

Phrase: "DNA binding experiments with purified proteins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0681814:Experiments [Research Activity]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.79: 2 were performed in 10 mM Tris pH 8.0, 0.01% Nonidet P-40, 10% glycerol, 1 mM DTT, 1 mM PMSF using the indicated salt (24). 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "were"

Phrase: "performed in 10 mM Tris pH 8.0,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   744   C0020283:[pH] [Quantitative Concept]
   744   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   744   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   744   C0450407:ph+ [Finding]
   744   C0450408:ph++ [Finding]
   744   C0450409:ph+++ [Finding]
   744   C0814229:TRI [Intellectual Product]
   744   C0884358:Performed [Functional Concept]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "0.01% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "1 mM PMSF"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the indicated salt"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0036140:Salt [Chemical Viewed Structurally]
   861   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0206136:Salt [Food,Inorganic Chemical]
   789 E C1537053:salty [Qualitative Concept]
   761 E C0678584:saltiness [Qualitative Concept]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.80: When indicated, an aliquot of ssDNA cellulose was equilibrated with buffer A containing 1 mM CaCl2 and digested with micrococcal nuclease. 

Phrase: "When"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "an aliquot of ssDNA cellulose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510844:Aliquot [Quantitative Concept]

Phrase: "was"

Phrase: "equilibrated with buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "A containing 1 mM CaCl2"

Phrase: "and"

Phrase: "digested with micrococcal nuclease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0025965:Micrococcal Nuclease [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0597094:nuclease [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0868946:digested [Physiologic Function]
Processing 00000000.tx.81: The reaction was stopped by addition of 1 mM EGTA and the column was equilibrated in buffer D containing 100 mM salt. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped by addition of 1 mM EGTA"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   774   C1418486:MM-1 [Gene or Genome]
   748   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C1272691:stopped [Qualitative Concept]
   748   C1883712:Addition [Functional Concept]
   714 E C1947925:Stop [Activity]
   714 E C2746065:Stop [Temporal Concept]

Phrase: "and"

Phrase: "the column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "was"

Phrase: "equilibrated in buffer D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100 mM salt."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0036140:Salt [Chemical Viewed Structurally]
   827   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0206136:Salt [Food,Inorganic Chemical]
   755 E C1537053:salty [Qualitative Concept]
   727 E C0678584:saltiness [Qualitative Concept]
Processing 00000000.tx.82: View larger version (38K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(38K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.83: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.84: RPA-dependent and -independent DNA binding of ATRIP in vitro. 

Phrase: "RPA-dependent"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0851827:Dependent [Qualitative Concept]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]
   756   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1167121:replication protein A [Cell Component]

Phrase: "and -"

Phrase: "independent DNA binding of ATRIP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1148673:DNA Binding [Genetic Function]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.85: A, HeLa nuclear extract (200 g) was loaded onto a 200 l ssDNA cellulose column, then washed sequentially with buffer D containing 100 mM NaCl, 400 mM NaCl and then 10% SDS. 

Phrase: "A,"

Phrase: "HeLa nuclear extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1518434:Nuclear Extract [Biomedical or Dental Material]
   827   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "(200 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "loaded onto a 200 l ssDNA cellulose column,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   744   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   744   C1185738:Column [Body Part, Organ, or Organ Component]
   744   C1706132:Column [Idea or Concept]
   744   C1708715:Loaded [Activity]
   711 E C1550025:Load [Idea or Concept]
   711 E C1704782:Load [Manufactured Object]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "sequentially with buffer D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "400 mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "then 10% SDS."
Processing 00000000.tx.86: 75% of the first 400 mM NaCl elution was diluted to 100 mM NaCl, applied to a second ssDNA cellulose column, and washed with the buffers described above. 

Phrase: "75% of the first 400 mM NaCl elution"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   744   C0205435:First [Quantitative Concept]
   744   C1279901:First [Qualitative Concept]
   744   C1441565:Elution [Laboratory Procedure]
   744   C1959973:% NaCl [Quantitative Concept]

Phrase: "was"

Phrase: "diluted to 100 mM NaCl,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C1959973:% NaCl [Quantitative Concept]
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]

Phrase: "applied to a second ssDNA cellulose column,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   748   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   748   C0185125:Applied [Health Care Activity]
   748   C0205436:Second [Quantitative Concept]
   748   C0457385:Second [Temporal Concept]
   748   C0565930:/second [Quantitative Concept]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1561503:second [Idea or Concept]
   748   C1705190:Second [Qualitative Concept]
   748   C1706132:Column [Idea or Concept]
   738   C0175668:Secondary to [Temporal Concept]
   714 E C1632850:Apply [Functional Concept]
   714 E C1879355:Apply [Functional Concept]

Phrase: "and"

Phrase: "washed with the buffers"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0006353:Buffers [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1548982:Washed [Idea or Concept]
   737 E C0441648:Wash [Activity]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.87: Proteins were analyzed with the indicated antibodies after SDS-PAGE and transfer to polyvinylidene difluoride. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "analyzed with the indicated antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0936012:Analyzed [Research Activity]
   760   C1444656:Indicated [Finding]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "after SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "transfer to polyvinylidene difluoride."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040671:Transfer [Mental Process]
   770   C1705822:Transfer [Activity]
Processing 00000000.tx.88: B, affinity-purified FATRIP was incubated with bovine serum albumin (top panel), RPA (middle panels), or 100 g of HeLa nuclear extract (bottom panels) and applied to 100-l ssDNA cellulose columns. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "affinity-purified FATRIP"

Phrase: "was"

Phrase: "incubated with bovine serum albumin"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   862   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   806   C0728877:serum albumin [Laboratory or Test Result]
   797 E C0523465:Albumin - serum [Laboratory Procedure]
   760   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0007452:Bovine [Mammal]
   760   C0229671:Serum [Body Substance]
   760   C1140701:bovine [Mammal]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]

Phrase: "(top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "RPA"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]

Phrase: "(middle panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "100 g of HeLa nuclear extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439267:g% [Quantitative Concept]

Phrase: "(bottom panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "applied to 100-l ssDNA cellulose columns."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   748   C0185125:Applied [Health Care Activity]
   714   C1185738:Column [Body Part, Organ, or Organ Component]
   714 E C1632850:Apply [Functional Concept]
   714   C1706132:Column [Idea or Concept]
   714 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.89: All columns were washed with buffer containing 100 mM NaCl, 400 mM NaCl, and 10% SDS prior to separation of samples by SDS-PAGE and blotting with the indicated antibodies.  

Phrase: "All columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1185738:Column [Body Part, Organ, or Organ Component]
   966   C1706132:Column [Idea or Concept]

Phrase: "were"

Phrase: "washed with buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C1548982:Washed [Idea or Concept]
   756 E C0441648:Wash [Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "400 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "10% SDS prior to separation of samples"

Phrase: "by SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "blotting with the indicated antibodies."
Processing 00000000.tx.90: Transfection and Affinity PurificationTransfection of human 293T cells was performed with Fugene-6 (Roche Applied Science) according to the manufacturer's protocol. 

Phrase: "Transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "Affinity PurificationTransfection of human 293T cells"

Phrase: "was"

Phrase: "performed with Fugene-6"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0916399:FuGene 6 [Lipid]
           FuGene
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ")"

Phrase: "according to the manufacturer's protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.91: For affinity purification, whole cell extract derived from 1 x 108 cells lysed in modified TGN buffer was mixed with 20 l of M2 resin for 1 h at 4 C. 

Phrase: "For affinity purification,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008551:affinity purification [Laboratory Procedure]
   861   C0243114:purification [Functional Concept]
   861   C1998793:Purification [Functional Concept]

Phrase: "whole cell extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "derived from 1 x 108 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C1441547:Derived [Qualitative Concept]
   753   C3245521:derived [Idea or Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "lysed in modified TGN buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0024348:lysed [Pathologic Function]
   760   C0392747:Modified [Functional Concept]
   760   C0887838:TGN [Cell Component]
   760   C1420709:TGN [Gene or Genome]

Phrase: "was"

Phrase: "mixed with 20 l of M2 resin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0035191:Resin [Biomedical or Dental Material]
   748   C0205430:Mixed [Functional Concept]
   748   C0457242:m2 [Quantitative Concept]
   748   C3160715:Mixed [Finding]
   714 E C1421951:MIX [Gene or Genome]
   714 E C1720722:Mix [Qualitative Concept]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]
Processing 00000000.tx.92: Beads were washed sequentially with the same buffer, 100 mM Tris-HCl pH 7.5 containing 0.5 M LiCl, and D100. 

Phrase: "Beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "sequentially with the same buffer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0445247:Same [Qualitative Concept]

Phrase: "100 mM Tris-HCl pH 7.5"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   818   C1882074:pH 7 [Qualitative Concept]
   795   C0020283:[pH] [Quantitative Concept]
   795   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   795   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]
   795   C0814229:TRI [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5 M LiCl,"

Phrase: "and"

Phrase: "D100."
Processing 00000000.tx.93: Activity of FATR was assessed using an in vitro kinase assay (28) with 0.5 g of GST-Rad17 peptide substrate (29). 

Phrase: "Activity of FATR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C1706704:Active Flag [Functional Concept]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an in vitro kinase assay"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C1515653:In Vitro Assay [Research Activity]
   861   C0021135:In Vitro [Intellectual Product]
   861   C1533691:in vitro [Qualitative Concept]
           vitro
   861   C2827718:In Vitro [Functional Concept]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "(28"

Phrase: ")"

Phrase: "with 0.5 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439267:g% [Quantitative Concept]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "of GST-Rad17 peptide substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1710236:Substrate [Manufactured Object]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.94: FLAG proteins were eluted with equal volume of D100 containing 250 g/ml FLAG tripeptide (Sigma), 0.05% Tween 20, and 1 mg/ml bovine serum albumin at 4 C for 30 min. 

Phrase: "FLAG proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "eluted with equal volume of D100"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205163:Equal [Qualitative Concept]
   753   C0449468:*Volume [Quantitative Concept]
   753   C1549782:Equal [Idea or Concept]
   753   C1690016:% volume [Qualitative Concept]
   753   C1705102:Volume [Intellectual Product]
   753   C2700258:Volume [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "250 g/ml FLAG tripeptide"

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "0.05% Tween 20,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "1 mg/ml bovine serum albumin at 4 C"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   764   C0728877:serum albumin [Laboratory or Test Result]
   762 E C0523465:Albumin - serum [Laboratory Procedure]
   742   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0007452:Bovine [Mammal]
   742   C0229671:Serum [Body Substance]
   742   C1140701:bovine [Mammal]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.95: Three consecutive eluents were pooled and used for DNA binding. 

Phrase: "Three consecutive eluents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C3469601:Eluent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: "and"

Phrase: "used for DNA binding."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C1148673:DNA Binding [Genetic Function]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.96: RPA was purified as described previously (30).  

Phrase: "RPA"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]

Phrase: "was"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.97: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  ATR and ATRIP Associate with ChromatinPrevious reports have shown that ATR is a nuclear protein that binds to chromatin even in the absence of external genotoxic stress (13). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "Associate with ChromatinPrevious"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "is"

Phrase: "a nuclear protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0028589:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "that"

Phrase: "binds to chromatin even"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1325550:chromatin [Cell Component]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of external genotoxic stress"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1257899:Genotoxic Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.98: In order to assess whether ATRIP can also associate with chromatin, subcellular fractionation was performed as previously described (27). 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "whether"

Phrase: "ATRIP"

Phrase: "can"

Phrase: "also"

Phrase: "associate with chromatin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
   790   C0750490:Associate [Idea or Concept]
   790   C1325550:chromatin [Cell Component]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "subcellular fractionation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1656251:subcellular fractionation [Laboratory Procedure]
   861   C0016640:fractionation [Laboratory Procedure]
   861   C0524811:fractionation [Therapeutic or Preventive Procedure]
   861   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.99: Exponentially growing 293T cells were collected and fractionated into three different parts: the cytoplasmic fraction (S1), the soluble nuclear fraction (S2), and the chromatin-enriched fraction (P2). 

Phrase: "Exponentially"

Phrase: "growing"

Phrase: "293T cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "fractionated into three different parts"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205449:Three [Quantitative Concept]
   760   C0449719:parts [Spatial Concept]
   760   C1705242:Different [Qualitative Concept]
   760   C1709471:PARTS [Quantitative Concept]
   760   C1979893:Fractionated [Qualitative Concept]

Phrase: ":"

Phrase: "the cytoplasmic fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "(S1"

Phrase: ")"

Phrase: ","

Phrase: "the soluble nuclear fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "(S2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179705:S2 [Body Location or Region]
  1000   C1419032:S2 [Gene or Genome]
  1000   C1419718:S2 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the chromatin-enriched fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "(P2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.100: Insulin-degrading enzyme (IDE), a soluble cytoplasmic protein, and ORC2, a chromatin-binding protein that is a subunit of the origin recognition complex, were readily separated into their appropriate fractions using this protocol. 

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "a soluble cytoplasmic protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1333198:Cytoplasmic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "ORC2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1335084:ORC2 [Gene or Genome]
  1000   C1335135:ORC2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1705278:ORC2 [Gene or Genome]

Phrase: "a chromatin-binding protein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0598996:chromatin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1148677:chromatin binding [Genetic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "that"

Phrase: "is"

Phrase: "a subunit of the origin recognition complex,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1711351:Subunit [Quantitative Concept]

Phrase: "were"

Phrase: "readily"

Phrase: "separated into their appropriate fractions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1264633:Fractions [Quantitative Concept]
   760   C1548787:Appropriate [Qualitative Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442711:Protocol [Intellectual Product]
  1000   C1507394:Protocol [Intellectual Product]
  1000   C1522729:Protocol [Intellectual Product]
  1000   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.101: As previously reported, ATR was found in the chromatin-enriched fraction (P2) as well as those fractions containing cytoplasmic and soluble nuclear proteins (Fig. 1A). 

Phrase: "As"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: ","

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "was"

Phrase: "found in the chromatin-enriched fraction"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
   753   C0150312:Found [Quantitative Concept]
   753   C0359583:enriched [Food]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1325550:chromatin [Cell Component]
   753   C1554103:Fraction [Idea or Concept]
   719 E C0243095:Find [Finding]

Phrase: "(P2)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "as well as"

Phrase: "those fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "cytoplasmic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010834:Cytoplasmic [Cell Component]
  1000   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and"

Phrase: "soluble nuclear proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0028589:Nuclear Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867 E C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0521447:Nuclear [Spatial Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.102: ATRIP distributed to the same fractions as ATR (Fig. 1A), and its distribution did not change significantly in response to genotoxic stress (data not shown). 

Phrase: "ATRIP"

Phrase: "distributed to the same fractions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0445247:Same [Qualitative Concept]
   760   C1264633:Fractions [Quantitative Concept]
   760   C1704711:Distributed [Functional Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "as ATR (Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "its distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520511:distribution [Idea or Concept]
  1000   C1704711:Distribution [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "significantly in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to genotoxic stress"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1257899:Genotoxic Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.103: Importantly, treatment of the chromatin-enriched fraction (P2) with micrococcal nuclease led to release of ATR, ATRIP, and ORC2 to the soluble nuclear fraction (S2), suggesting that both ATR and ATRIP associate specifically with chromatin. 

Phrase: "Importantly,"

Phrase: "treatment of the chromatin-enriched fraction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "(P2) with micrococcal nuclease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1384585:P2 [Immunologic Factor]
   770   C1419693:P2 [Gene or Genome]
   770   C1539372:p2 [Gene or Genome]

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "release of ATR,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0030685:Release [Health Care Activity]
   790   C0391871:Release [Functional Concept]
   790   C0439180:% release [Quantitative Concept]
   790   C0680255:release [Health Care Activity]
   790   C1283071:Release [Functional Concept]
   790   C1963578:Release [Therapeutic or Preventive Procedure]
   790   C3540546:ATR [Gene or Genome]

Phrase: "ATRIP,"

Phrase: "and"

Phrase: "ORC2 to the soluble nuclear fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1335084:ORC2 [Gene or Genome]
   753   C1335135:ORC2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1705278:ORC2 [Gene or Genome]

Phrase: "(S2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179705:S2 [Body Location or Region]
  1000   C1419032:S2 [Gene or Genome]
  1000   C1419718:S2 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "both ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "associate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: "specifically with chromatin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
   790   C1325550:chromatin [Cell Component]
Processing 00000000.tx.104: View larger version (29K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.105: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.106: ATR and ATRIP bind chromatin and ssDNA cellulose. 

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "chromatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
  1000   C1325550:chromatin [Cell Component]

Phrase: "and"

Phrase: "ssDNA cellulose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
Processing 00000000.tx.107: A, exponentially growing 293T cells were collected and fractionated into cytoplasmic (S1), nuclear soluble (S2), and nuclear insoluble (P2) fractions or a whole cell extract (WCE) of the total protein was prepared. 

Phrase: "A,"

Phrase: "exponentially"

Phrase: "growing"

Phrase: "293T cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "fractionated into cytoplasmic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010834:Cytoplasmic [Cell Component]
   790   C0521449:Cytoplasmic [Body Location or Region]
   790   C1979893:Fractionated [Qualitative Concept]

Phrase: "(S1"

Phrase: ")"

Phrase: ","

Phrase: "nuclear soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1749467:soluble [Cell Component]
   861   C1948047:Soluble [Qualitative Concept]

Phrase: "(S2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179705:S2 [Body Location or Region]
  1000   C1419032:S2 [Gene or Genome]
  1000   C1419718:S2 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "nuclear insoluble"

Phrase: "(P2) fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "or"

Phrase: "a whole cell extract (WCE) of the total protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2828366:Extract [Substance]

Phrase: "was"

Phrase: "prepared."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.108: A portion of the nuclear insoluble fraction (P2) was treated with micrococcal nuclease (MNase) to release chromatin-bound proteins into the S2 fraction. 

Phrase: "A portion of the nuclear insoluble fraction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449719:Portion [Spatial Concept]

Phrase: "(P2)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "was"

Phrase: "treated with micrococcal nuclease (MNase) to"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0025965:Micrococcal Nuclease [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0597094:nuclease [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "chromatin-bound proteins into the S2 fraction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0522527:Protein bound [Qualitative Concept]
   757   C0598996:chromatin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.109: Proteins were then separated by SDS-PAGE, transferred to polyvinylidene difluoride, and detected by blotting with the indicated antibodies. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "separated by SDS-PAGE,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "transferred to polyvinylidene difluoride,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0071710:polyvinylidene difluoride [Organic Chemical]
   770   C0348011:transferred [Functional Concept]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "detected by blotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with the indicated antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.110: B, a nuclear extract (200 g) prepared from HeLa cells was loaded onto a 200 l ssDNA cellulose column that had been either mock-treated (top two panels) or previously treated with MNase (bottom two panels) followed by equilibration in buffer D containing 100 mM salt. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "a nuclear extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   861   C2828366:Extract [Substance]

Phrase: "(200 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "prepared from HeLa cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0018873:HeLa Cells [Cell]
           HeLa
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1521827:Prepare [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "loaded onto a 200 l ssDNA cellulose column"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   744   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   744   C1185738:Column [Body Part, Organ, or Organ Component]
   744   C1706132:Column [Idea or Concept]
   744   C1708715:Loaded [Activity]
   711 E C1550025:Load [Idea or Concept]
   711 E C1704782:Load [Manufactured Object]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "either mock-treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332293:treated [Therapeutic or Preventive Procedure]
   827   C1522326:Treated [Functional Concept]
   793 E C1292734:TREAT [Functional Concept]

Phrase: "(top two panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "previously"

Phrase: "treated with MNase"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0025965:Micrococcal Nuclease [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0597094:nuclease [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(bottom two panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "followed by equilibration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "in buffer D"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100 mM salt."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0036140:Salt [Chemical Viewed Structurally]
   827   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0206136:Salt [Food,Inorganic Chemical]
   755 E C1537053:salty [Qualitative Concept]
   727 E C0678584:saltiness [Qualitative Concept]
Processing 00000000.tx.111: Columns were washed sequentially with buffer D containing 100 mM and then 400 mM salt. 

Phrase: "Columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1185738:Column [Body Part, Organ, or Organ Component]
   966   C1706132:Column [Idea or Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "sequentially with buffer D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100 mM"

Phrase: "and"

Phrase: "then 400 mM salt."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0036140:Salt [Chemical Viewed Structurally]
   812   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0206136:Salt [Food,Inorganic Chemical]
   741 E C1537053:salty [Qualitative Concept]
   712 E C0678584:saltiness [Qualitative Concept]
Processing 00000000.tx.112: Load (L), flow-through (FT), and eluted proteins were separated by SDS-PAGE and blotted with the indicated antibodies.  

Phrase: "Load (L),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]

Phrase: "flow-through (FT),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "eluted proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "blotted with the indicated antibodies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C1444656:Indicated [Finding]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.113: ATR and ATRIP Bind DNA in VitroOur data show that ATR and ATRIP are both able to bind chromatin in vivo, suggesting that these proteins may also interact with DNA in vitro. 

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "Bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA in VitroOur data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "are"

Phrase: "both able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "chromatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
  1000   C1325550:chromatin [Cell Component]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "also"

Phrase: "interact with DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.114: To test this possibility, we assessed the ability of both proteins to interact with ssDNA cellulose. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "we"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the ability of both proteins to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "interact with ssDNA cellulose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
Processing 00000000.tx.115: Using HeLa nuclear extract as a source of ATR and ATRIP, we found that both ATR and ATRIP can bind ssDNA cellulose with the majority of both proteins eluting at 400 mM NaCl (Fig. 1B, top panel). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "HeLa nuclear extract as a source of ATR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1518434:Nuclear Extract [Biomedical or Dental Material]
   744   C0521447:Nuclear [Spatial Concept]
   744   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "ATRIP,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "both ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "can"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "ssDNA cellulose with the majority of both proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]

Phrase: "eluting at 400 mM NaCl (Fig. 1B,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   748   C0349966:Fig [Food]
   748   C0450345:1B [Intellectual Product]
   748   C1337208:FIG [Food]
   748   C1959973:% NaCl [Quantitative Concept]

Phrase: "top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.116: A gradient from 100 mM to 1 M NaCl revealed that this elution began to occur at 200 mM NaCl, and similar results were obtained with nuclear extracts prepared from 293T or HCT116 cells (data not shown). 

Phrase: "A gradient from 100 mM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439182:% gradient [Quantitative Concept]
   760   C0812409:Gradient [Quantitative Concept]

Phrase: "to 1 M NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "this elution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441565:Elution [Laboratory Procedure]

Phrase: "began"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur at 200 mM NaCl,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C1709305:Occur [Activity]
   760   C1959973:% NaCl [Quantitative Concept]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained with nuclear extracts"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   799   C1518434:Nuclear Extract [Biomedical or Dental Material]
   770   C0521447:Nuclear [Spatial Concept]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
   737   C2828366:Extract [Substance]

Phrase: "prepared from 293T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1521827:Prepare [Functional Concept]

Phrase: "or"

Phrase: "HCT116 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1258005:HCT116 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.117: To test the specificity of binding, we treated the ssDNA cellulose with micrococcal nuclease prior to addition of HeLa nuclear extract. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the specificity of binding,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037791:Specificity [Quantitative Concept]
   770   C1511884:Specificity [Quantitative Concept]

Phrase: "we"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "the ssDNA cellulose with micrococcal nuclease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]

Phrase: "prior to addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of HeLa nuclear extract."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1518434:Nuclear Extract [Biomedical or Dental Material]
   827   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]
Processing 00000000.tx.118: Both ATR and ATRIP were unable to bind to the micrococcal nuclease-treated DNA cellulose (Fig. 1B, bottom panel). 

Phrase: "Both ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "bind to the micrococcal nuclease-treated DNA cellulose"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0025965:Micrococcal Nuclease [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0058604:DNA-cellulose [Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0332293:treated [Therapeutic or Preventive Procedure]
   744   C0597094:nuclease [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1145667:Bind [Activity]
   744   C1167622:bind [Molecular Function]
   744   C1522326:Treated [Functional Concept]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.119: Together, these results indicate that native, unpurified ATR and ATRIP can bind ssDNA. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that native, unpurified ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "can"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "ssDNA."
Processing 00000000.tx.120: ATRIP Binds DNA in an RPA-dependent and -independent MannerRecent studies using extracts from the eggs of Xenopus laevis implicate RPA in the association of ATR with poly(dA) oligonucleotides or with sperm chromatin (31, 32), and studies with purified proteins also indicate that RPA is required for the association of human ATRIP with single-stranded DNA oligonucleotides (24). 

Phrase: "ATRIP"

Phrase: "Binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA in an RPA-dependent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0058610:protein dna [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0598312:DNA Replication [Genetic Function]
   774   C2984261:DNA replication [Functional Concept]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and -"

Phrase: "independent MannerRecent studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   896   C0681367:independent study [Educational Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "extracts from the eggs of Xenopus laevis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C1508746:egg extract [Organic Chemical,Pharmacologic Substance]
   714   C2828366:Extract [Substance]

Phrase: "implicate"

Phrase: "RPA in the association of ATR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C1167121:replication protein A [Cell Component]
   770   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0598312:Replication [Genetic Function]
   744   C1883725:replication [Qualitative Concept]

Phrase: "with poly(dA) oligonucleotides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0071404:poly dA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or with sperm chromatin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
   770   C0037868:Sperm [Cell]
   770   C1325550:chromatin [Cell Component]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "studies with purified proteins also"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0557651:Study [Manufactured Object]
   760   C0947630:studies [Laboratory Procedure]
   760   C1998793:Purified [Functional Concept]
   760   C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that RPA"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]

Phrase: "is"

Phrase: "required for the association of human ATRIP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0004083:Association [Mental Process]
   748   C0086418:Human [Human]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]
   748   C1514873:Required [Functional Concept]

Phrase: "with single-stranded DNA oligonucleotides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0012935:DNA, Single-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.121: Therefore, we directly tested the requirement for RPA in the binding of ATR and ATRIP to ssDNA cellulose. 

Phrase: "Therefore,"

Phrase: "we directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the requirement for RPA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0556043:Protein requirement [Finding]
   753   C1514873:Requirement [Functional Concept]

Phrase: "in the binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "of ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP to ssDNA cellulose."
Processing 00000000.tx.122: To do so, a HeLa nuclear extract was first passed over a ssDNA cellulose column and bound proteins were eluted with sequential washes of 400 mM NaCl buffer and 10% SDS. 

Phrase: "To do so,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1883351:To [Qualitative Concept]

Phrase: "a HeLa nuclear extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1518434:Nuclear Extract [Biomedical or Dental Material]
   827   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "passed over a ssDNA cellulose column"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
   753   C2828386:Passed [Finding]

Phrase: "and"

Phrase: "bound proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "eluted with sequential washes of 400 mM NaCl buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   742   C1548958:Sequential [Idea or Concept]
   742   C1705294:Sequential [Qualitative Concept]
   742   C1959973:% NaCl [Quantitative Concept]
   708   C0441648:Wash [Activity]

Phrase: "and"

Phrase: "10% SDS."
Processing 00000000.tx.123: Consistent with previous reports that RPA requires at least 2 M NaCl for elution (33), we found that RPA remained tightly bound to the column and was eluted only with 10% SDS (Fig. 2A, column 1). 

Phrase: "Consistent with previous"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that RPA"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]

Phrase: "requires at least 2 M NaCl"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C1959973:% NaCl [Quantitative Concept]

Phrase: "for elution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441565:Elution [Laboratory Procedure]

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that RPA"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]

Phrase: "remained"

Phrase: "tightly"

Phrase: "bound to the column"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1185738:Column [Body Part, Organ, or Organ Component]
   770   C1689898:% bound [Quantitative Concept]
   770   C1706132:Column [Idea or Concept]
   770   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "was"

Phrase: "eluted"

Phrase: "only with 10% SDS (Fig. 2A,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205171:Only [Quantitative Concept]
   753   C0349966:Fig [Food]
   753   C1337208:FIG [Food]
   753   C1720467:Only [Intellectual Product]

Phrase: "column 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.124: Although ATR and ATRIP eluted at 400 mM NaCl as before, we did find that a small fraction remained bound to ssDNA and eluted with RPA (Fig. 2A, column 1, last lane). 

Phrase: "Although"

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "eluted at 400 mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C1959973:% NaCl [Quantitative Concept]

Phrase: "as"

Phrase: "before,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Before [Temporal Concept]
  1000   C1705850:Before [Intellectual Product]

Phrase: "we"

Phrase: "did"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that"

Phrase: "a small fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "remained"

Phrase: "bound to ssDNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "eluted with RPA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1167121:replication protein A [Cell Component]
   806   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0598312:Replication [Genetic Function]
   760   C1883725:replication [Qualitative Concept]

Phrase: "(Fig. 2A,"

Phrase: "column 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "last lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.125: We then reapplied the ATR and ATRIP that eluted with 400 mM NaCl to a second ssDNA cellulose column equilibrated to 100 mM NaCl. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "reapplied"

Phrase: "the ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "that"

Phrase: "eluted with 400 mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C1959973:% NaCl [Quantitative Concept]

Phrase: "to a second ssDNA cellulose column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1185738:Column [Body Part, Organ, or Organ Component]
   812   C1706132:Column [Idea or Concept]

Phrase: "equilibrated to 100 mM NaCl."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C1959973:% NaCl [Quantitative Concept]
Processing 00000000.tx.126: Bound proteins were again eluted sequentially with 400 mM NaCl and 10% SDS. 

Phrase: "Bound proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "again"

Phrase: "eluted"

Phrase: "sequentially with 400 mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "10% SDS."
Processing 00000000.tx.127: Interestingly, we found that the ATR and ATRIP in these RPA-depleted fractions were still able to bind ssDNA cellulose (Fig. 2A, column 2). 

Phrase: "Interestingly,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP in these RPA-depleted fractions"

Phrase: "were"

Phrase: "still able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "ssDNA cellulose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]

Phrase: "(Fig. 2A,"

Phrase: "column 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.128: These results suggest that the ATR-ATRIP complex that elutes from ssDNA cellulose at 400 mM NaCl does not require RPA to bind to DNA in vitro. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the ATR-ATRIP complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2611008:ATR-ATRIP complex [Cell Component]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "elutes from ssDNA cellulose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]

Phrase: "at 400 mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "RPA to"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   923   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1167121:replication protein A [Cell Component]
   861   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0598312:Replication [Genetic Function]
   812   C1883725:replication [Qualitative Concept]
   741 E C0205173:Replicate [Functional Concept]
   741 E C0205341:Replicate [Functional Concept]

Phrase: "bind to DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.129: One explanation for this observation that would reconcile it with previous reports is that there are distinct ATR-ATRIP complexes that can bind DNA in an RPA-dependent and RPA-independent manner. 

Phrase: "One explanation for this observation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0681841:Explanation [Intellectual Product]

Phrase: "that"

Phrase: "would"

Phrase: "reconcile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1960278:RECONCILE [Organic Chemical,Pharmacologic Substance]

Phrase: "it with previous reports"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205156:Previous [Temporal Concept]
   770   C0684224:Reports [Intellectual Product]
   770   C0700287:reports [Health Care Activity]
   770   C1552607:previous [Temporal Concept]
   737 E C3273238:Report [Intellectual Product]

Phrase: "is"

Phrase: "that there"

Phrase: "are"

Phrase: "distinct ATR-ATRIP complexes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   912   C2611008:ATR-ATRIP complex [Cell Component]
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "that"

Phrase: "can"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA in an RPA-dependent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0058610:protein dna [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0598312:DNA Replication [Genetic Function]
   774   C2984261:DNA replication [Functional Concept]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "RPA-independent manner."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1167121:replication protein A [Cell Component]
Processing 00000000.tx.130: To more directly test for the presence of multiple ATR-ATRIP ssDNA binding complexes in vitro, we compared the ability of RPA to reconstitute the binding of affinity-purified FLAG-tagged ATRIP (FATRIP) (Fig. 2B) and/or FATR (data not shown). 

Phrase: "To more directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883351:To [Qualitative Concept]
   827   C1947931:Directly [Qualitative Concept]

Phrase: "test for the presence of multiple ATR-ATRIP ssDNA binding complexes"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   761   C2611008:ATR-ATRIP complex [Cell Component]
   756   C1148754:ssDNA binding [Genetic Function]
   738   C0022885:Test [Laboratory Procedure]
   738   C0039593:Test [Functional Concept]
   738   C0243122:binding [Functional Concept]
   738   C0392148:Presence [Therapeutic or Preventive Procedure]
   738   C0392366:test [Intellectual Product]
   738   C0439064:Multiple [Quantitative Concept]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1704241:Complexes [Chemical Viewed Structurally]
   738   C3540546:ATR [Gene or Genome]
   704 E C0439855:Complex [Qualitative Concept]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the ability of RPA to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "reconstitute"

Phrase: "the binding of affinity-purified FLAG-tagged ATRIP (FATRIP)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: "and/or"

Phrase: "FATR (data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.131: Consistent with the results of Zou and Elledge (24) who used ssDNA oligonucleotides, when ATRIP alone was incubated with ssDNA cellulose in a similar buffer (see "Experimental Procedures"), none was able to bind DNA (Fig. 2B, top panel). 

Phrase: "Consistent with the results of Zou"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "and"

Phrase: "Elledge"

Phrase: "(24"

Phrase: ")"

Phrase: "who"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ssDNA oligonucleotides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "when"

Phrase: "ATRIP"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "was"

Phrase: "incubated with ssDNA cellulose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in a similar buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "none"

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.132: However, inclusion of RPA with ATRIP led to the recruitment of some ATRIP to ssDNA. 

Phrase: "However,"

Phrase: "inclusion of RPA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1512693:Inclusion [Qualitative Concept]

Phrase: "with ATRIP"

Phrase: "led to the recruitment of some ATRIP"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   748   C1708698:LED [Manufactured Object]
   748   C2949735:Recruitment [Activity]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to ssDNA."
Processing 00000000.tx.133: Although this population of ATRIP did not elute at 400 mM NaCl, it could be eluted with 10% SDS (Fig. 2B, middle panel). 

Phrase: "Although"

Phrase: "this population of ATRIP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "elute at 400 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C1959973:% NaCl [Quantitative Concept]

Phrase: "it"

Phrase: "could"

Phrase: "be"

Phrase: "eluted with 10% SDS (Fig. 2B,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0349966:Fig [Food]
   753   C0450354:2b [Intellectual Product]
   753   C1337208:FIG [Food]
   753   C1706096:2B [Research Activity]

Phrase: "middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.134: In contrast, when ATRIP was incubated with HeLa nuclear extract, two populations of ATRIP DNA binding could be observed, one of which eluted at 400 mM NaCl and the other with 10% SDS (Fig. 2B, bottom panel). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "when"

Phrase: "ATRIP"

Phrase: "was"

Phrase: "incubated with HeLa nuclear extract,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1518434:Nuclear Extract [Biomedical or Dental Material]
   760   C0018873:HeLa [Cell]
   760   C0521447:Nuclear [Spatial Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C2828366:Extract [Substance]

Phrase: "two populations of ATRIP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]

Phrase: "DNA binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1148673:DNA Binding [Genetic Function]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "could"

Phrase: "be"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "one of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "eluted at 400 mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "the other with 10% SDS (Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0450354:2b [Intellectual Product]
   804   C1706096:2B [Research Activity]

Phrase: "bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.135: This suggests that recombinant ATRIP is properly folded and that the HeLa nuclear extract provides another activity that is necessary for the interaction of ATRIP with ssDNA. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that recombinant ATRIP"

Phrase: "is"

Phrase: "properly"

Phrase: "folded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Folded [Spatial Concept]
  1000   C1880834:FOLDED [Phenomenon or Process]

Phrase: "and"

Phrase: "that"

Phrase: "the HeLa nuclear extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1518434:Nuclear Extract [Biomedical or Dental Material]
   827   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "another activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "is"

Phrase: "necessary for the interaction of ATRIP"

Phrase: "with ssDNA."
Processing 00000000.tx.136: Taken together, these observations indicate that two distinct ATR-ATRIP DNA binding modes exist, a high affinity mode that requires RPA for binding and a lower affinity mode that does not require RPA for binding. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "indicate"

Phrase: "that two distinct ATR-ATRIP DNA binding modes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1513371:Mode [Functional Concept]
   762   C1705738:Mode [Quantitative Concept]
   762   C2347637:Mode [Quantitative Concept]
   762   C2348146:Mode [Quantitative Concept]

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: ","

Phrase: "a high affinity mode"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1513371:Mode [Functional Concept]
   827   C1705738:Mode [Quantitative Concept]
   827   C2347637:Mode [Quantitative Concept]
   827   C2348146:Mode [Quantitative Concept]

Phrase: "that"

Phrase: "requires"

Phrase: "RPA for binding"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1167121:replication protein A [Cell Component]
   806   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   797   C0033618:Protein Binding [Molecular Function]
   797   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0598312:Replication [Genetic Function]
   760   C1883725:replication [Qualitative Concept]

Phrase: "and"

Phrase: "a lower affinity mode"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1513371:Mode [Functional Concept]
   827   C1705738:Mode [Quantitative Concept]
   827   C2347637:Mode [Quantitative Concept]
   827   C2348146:Mode [Quantitative Concept]

Phrase: "that"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "require"

Phrase: "RPA for binding."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1167121:replication protein A [Cell Component]
   806   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   797   C0033618:Protein Binding [Molecular Function]
   797   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0598312:Replication [Genetic Function]
   760   C1883725:replication [Qualitative Concept]
Processing 00000000.tx.137: ATR and ATRIP Are Part of a Large Molecular Weight DNA Binding ComplexIt is possible that the dual modes of ATR-ATRIP DNA binding in vitro represent multiple complexes in vivo. 

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "Are"

Phrase: "Part of a Large Molecular Weight DNA Binding ComplexIt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1292711:Part of [Spatial Concept]
   742   C0449719:Part [Spatial Concept]
   742   C1709471:Part [Quantitative Concept]

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the dual modes of ATR-ATRIP DNA binding in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   706   C1513371:Mode [Functional Concept]
   706   C1705738:Mode [Quantitative Concept]
   706   C2347637:Mode [Quantitative Concept]
   706   C2348146:Mode [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "multiple complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.138: ATR has been reported to exist in a large molecular weight complex (34), and previous immunoprecipitation studies show that ATRIP interacts with ATR (23). 

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exist in a large molecular weight complex"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0026385:Molecular Weight [Quantitative Concept]
   748   C0005910:weight [Organism Attribute]
   748   C0043100:Weight [Quantitative Concept]
   748   C0439855:Complex [Qualitative Concept]
   748   C0549177:Large [Quantitative Concept]
   748   C1305866:weight [Diagnostic Procedure]
   748   C1521991:Molecular [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]
   748   C1705104:Weight [Idea or Concept]
   748   C2987476:Exist [Conceptual Entity]

Phrase: "(34"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "previous immunoprecipitation studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that ATRIP"

Phrase: "interacts with ATR (23"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0450348:23 [Quantitative Concept]
   770   C3540546:ATR [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.139: To determine if ATRIP is also in the large ATR complex, HeLa nuclear lysates were fractionated by sucrose gradient sedimentation and size exclusion chromatography (Fig. 3, A and C). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "ATRIP"

Phrase: "is"

Phrase: "also in the large ATR complex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439855:Complex [Qualitative Concept]
   753   C0549177:Large [Quantitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]
   753   C3540546:ATR [Gene or Genome]

Phrase: "HeLa nuclear lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "fractionated by sucrose gradient sedimentation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0439182:% gradient [Quantitative Concept]
   760   C0597428:Sedimentation [Laboratory Procedure]
   760   C0812409:Gradient [Quantitative Concept]
   760   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   760   C1384604:Sedimentation [Natural Phenomenon or Process]
   760   C1979893:Fractionated [Qualitative Concept]

Phrase: "and"

Phrase: "size exclusion chromatography"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
  1000   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   827   C0008550:Chromatography [Laboratory Procedure]
   827   C0456389:size [Spatial Concept]
   827   C0680251:EXCLUSION [Functional Concept]
   827   C2828389:Exclusion [Activity]
   727 E C0302647:chromatograph [Medical Device]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "C"

Phrase: ")."
Processing 00000000.tx.140: ATRIP and ATR were found in the same fractions using both techniques. 

Phrase: "ATRIP"

Phrase: "and"

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "were"

Phrase: "found in the same fractions"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0150312:Found [Quantitative Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C0243095:Find [Finding]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both techniques."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025664:techniques [Intellectual Product]
  1000   C0449851:Techniques [Functional Concept]
Processing 00000000.tx.141: Furthermore, the size distribution of ATR and ATRIP did not appear to change upon DNA damage, inhibition of replication, or DNase I treatment (data not shown). 

Phrase: "Furthermore,"

Phrase: "the size distribution of ATR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "change upon DNA damage,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   770   C0010957:Damage [Injury or Poisoning]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]
   770   C1883709:Damage [Functional Concept]

Phrase: "inhibition of replication,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "or"

Phrase: "DNase I treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0011519:DNAase I [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1148702:DNase I [Genetic Function]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.142: Importantly, RPA did not copurify with ATR and ATRIP by either technique suggesting it is not part of the ATR-ATRIP complex. 

Phrase: "Importantly,"

Phrase: "RPA"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "copurify with ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP by either technique"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "it"

Phrase: "is"

Phrase: "not part of the ATR-ATRIP complex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1292711:Part of [Spatial Concept]
   748   C0449719:Part [Spatial Concept]
   748   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.143: View larger version (35K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.144: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.145: ATR and ATRIP are in a large molecular weight DNA binding complex. 

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "are in a large molecular weight DNA binding complex."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   764   C0026385:Molecular Weight [Quantitative Concept]
   764   C1148673:DNA Binding [Genetic Function]
   742   C0005910:weight [Organism Attribute]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
           DNA molecule
   742   C0043100:Weight [Quantitative Concept]
   742   C0243122:binding [Functional Concept]
   742   C0439855:Complex [Qualitative Concept]
   742   C0549177:Large [Quantitative Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1305866:weight [Diagnostic Procedure]
   742   C1521991:Molecular [Qualitative Concept]
   742   C1551058:Are [Quantitative Concept]
   742   C1704241:Complex [Chemical Viewed Structurally]
   742   C1705104:Weight [Idea or Concept]
Processing 00000000.tx.146: A, HeLa nuclear extract (L) (100 g) was loaded onto a 530% sucrose density gradient and centrifuged for 3 h at 55,000 rpm. 

Phrase: "A,"

Phrase: "HeLa nuclear extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1518434:Nuclear Extract [Biomedical or Dental Material]
   827   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "(L"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]

Phrase: ")"

Phrase: "(100 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "loaded onto a 530% sucrose density gradient"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0178587:density [Quantitative Concept]
   748   C0439182:% gradient [Quantitative Concept]
   748   C0812409:Gradient [Quantitative Concept]
   748   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   748   C1708715:Loaded [Activity]
   714 E C1550025:Load [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]

Phrase: "and"

Phrase: "centrifuged for 3 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0041119:h 3 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0179834:centrifuge [Medical Device]

Phrase: "at 55,000 rpm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0582523:rpm [Quantitative Concept]
Processing 00000000.tx.147: Fractions were taken from the top of the gradient, separated by SDS-PAGE, and analyzed by blotting with the antibodies indicated. 

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "taken from the top of the gradient,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0439182:% gradient [Quantitative Concept]
   748   C0812409:Gradient [Quantitative Concept]
   748   C1704458:Top [Spatial Concept]
   748   C1883727:Taken [Conceptual Entity]
   714 E C1515187:Take [Health Care Activity]

Phrase: "separated by SDS-PAGE,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "analyzed by blotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]

Phrase: "with the antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.148: Molecular weight markers are shown. 

Phrase: "Molecular weight markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C0026385:Molecular Weight [Quantitative Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.149: B, schematic of partial purification of HeLa nuclear extract. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "schematic of partial purification of HeLa nuclear extract."
Processing 00000000.tx.150: Fractions from the S-300 gel filtration column (C) and ssDNA cellulose column (D) used in the purification are shown. 

Phrase: "Fractions from the S-300 gel filtration column (C)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1264633:Fractions [Quantitative Concept]
   711 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "ssDNA cellulose column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "("

Phrase: "D)"

Phrase: "used in the purification"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0243114:purification [Functional Concept]
   770   C1273517:used [Finding]
   770   C1998793:Purification [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.151: S-300 column void volume (Vo) and standard molecular weight markers are indicated. 

Phrase: "S-"

Phrase: "300 column void volume (Vo)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0042034:void [Organism Function]
   812   C0449468:*Volume [Quantitative Concept]
   812   C1552835:void [Idea or Concept]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]

Phrase: "and"

Phrase: "standard molecular weight markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0005516:molecular markers [Clinical Attribute]
           Marker

Phrase: "are"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.152: Fractions were collected and separated by SDS-PAGE and blotted with the indicated antibodies.  

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "blotted with the indicated antibodies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C1444656:Indicated [Finding]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.153: We also assessed the ability of ATR and ATRIP to bind ssDNA cellulose after further purification. 

Phrase: "We also"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the ability of ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "and"

Phrase: "ATRIP to"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "ssDNA cellulose after further purification."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
Processing 00000000.tx.154: Purification of HeLa nuclear extracts by ammonium sulfate precipitation followed by sequential fractionation on gel filtration (S-300), Q Sepharose and heparin Sepharose columns revealed that ATR and ATRIP copurify through multiple steps (Fig. 3, B and C and data not shown). 

Phrase: "Purification of HeLa nuclear extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243114:purification [Functional Concept]
   760   C1998793:Purification [Functional Concept]

Phrase: "by ammonium sulfate precipitation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0032931:Precipitation [Natural Phenomenon or Process]
   827   C0032932:Precipitation [Molecular Function]
   827   C1642401:% precipitation [Quantitative Concept]
   827   C2584299:Precipitation [Natural Phenomenon or Process]
   734   C0002620:Ammonium Sulfate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]

Phrase: "followed by sequential fractionation"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0016640:fractionation [Laboratory Procedure]
   770   C0524811:fractionation [Therapeutic or Preventive Procedure]
   770   C1548958:Sequential [Idea or Concept]
   770   C1705294:Sequential [Qualitative Concept]
   770   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "on gel filtration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0008559:Gel Filtration [Laboratory Procedure]
   861   C0016107:filtration [Laboratory Procedure]
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "("

Phrase: "S-"

Phrase: "300"

Phrase: ")"

Phrase: ","

Phrase: "Q Sepharose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036681:Sepharose [Carbohydrate]

Phrase: "and"

Phrase: "heparin Sepharose columns"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1185738:Column [Body Part, Organ, or Organ Component]
   793   C1706132:Column [Idea or Concept]
   734   C0062515:heparin-sepharose [Carbohydrate,Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "copurify through multiple steps"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0439064:Multiple [Quantitative Concept]
   770   C1261552:steps [Conceptual Entity]
   737 E C1704379:Step [Functional Concept]
   737 E C1705117:Step [Quantitative Concept]
   737 E C2825408:Step [Manufactured Object]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C"

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.155: Moreover, this complex retains the ability to bind ssDNA cellulose (Fig. 3D) in the absence of RPA. 

Phrase: "Moreover,"

Phrase: "this complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "retains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "ssDNA cellulose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]

Phrase: "(Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: ")"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of RPA."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]
Processing 00000000.tx.156: Overall, these results strongly suggest that ATR and ATRIP, but not RPA, are part of the same large molecular weight complex that elutes from ssDNA at 400 mM salt. 

Phrase: "Overall,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "these results strongly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP,"

Phrase: "but"

Phrase: "not RPA,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   923   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1167121:replication protein A [Cell Component]
   861   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0598312:Replication [Genetic Function]
   812   C1883725:replication [Qualitative Concept]
   741 E C0205173:Replicate [Functional Concept]
   741 E C0205341:Replicate [Functional Concept]

Phrase: "are"

Phrase: "part of the same large molecular weight complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1292711:Part of [Spatial Concept]
   744   C0449719:Part [Spatial Concept]
   744   C1709471:Part [Quantitative Concept]

Phrase: "that"

Phrase: "elutes from ssDNA"

Phrase: "at 400 mM salt."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0036140:Salt [Chemical Viewed Structurally]
   827   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0206136:Salt [Food,Inorganic Chemical]
   755 E C1537053:salty [Qualitative Concept]
   727 E C0678584:saltiness [Qualitative Concept]
Processing 00000000.tx.157: Henceforth, the ATR-ATRIP complex that binds ssDNA independently of RPA will also be referred to as the low affinity DNA binding complex. 

Phrase: "Henceforth,"

Phrase: "the ATR-ATRIP complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2611008:ATR-ATRIP complex [Cell Component]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "ssDNA independently of RPA"

Phrase: "will"

Phrase: "also"

Phrase: "be"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "the low affinity DNA binding complex."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C1148673:DNA Binding [Genetic Function]
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0243122:binding [Functional Concept]
   804   C0439855:Complex [Qualitative Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.158: ATR and ATRIP Are Not Sufficient to Bind ssDNA CelluloseThe results shown above indicate that ATR and ATRIP can associate with DNA both in vitro and in vivo, but it is not clear if ATR and ATRIP in the low affinity DNA binding complex interact directly with DNA or if additional proteins are required to mediate their interaction. 

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "Are"

Phrase: "Not Sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "Bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "ssDNA CelluloseThe results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "shown above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1547282:Show [Intellectual Product]

Phrase: "indicate"

Phrase: "that ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "can"

Phrase: "associate with DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "but"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "if"

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP in the low affinity DNA binding complex"

Phrase: "interact"

Phrase: "directly with DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1947931:Directly [Qualitative Concept]

Phrase: "or"

Phrase: "if"

Phrase: "additional proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "their interaction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.159: Studies in S. cerevisiae have shown that the putative ATRIP homolog Lcd1/Ddc2 can bind directly to ssDNA in vitro and can facilitate the interaction of Mec1 with DNA (21). 

Phrase: "Studies in S. cerevisiae"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the putative ATRIP homolog Lcd1/Ddc2"

Phrase: "can"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "directly to ssDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1947931:Directly [Qualitative Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "can"

Phrase: "facilitate"

Phrase: "the interaction of Mec1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.160: Thus, one possibility is that ATRIP is the factor that mediates the interaction of ATR with DNA independently of RPA. 

Phrase: "Thus,"

Phrase: "one possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that ATRIP"

Phrase: "is"

Phrase: "the factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the interaction of ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "independently of RPA."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]
Processing 00000000.tx.161: In contrast with Ldc1/Ddc2, however, baculovirus-expressed affinity-purified FATRIP did not bind to ssDNA cellulose (Fig. 2B, top panel and 4A, top panel). 

Phrase: "In contrast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "with Ldc1/Ddc2,"

Phrase: "however,"

Phrase: "baculovirus-expressed affinity-purified FATRIP"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind to ssDNA cellulose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "and"

Phrase: "4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450373:4a [Intellectual Product]
  1000   C1553636:4a [Medical Device]

Phrase: "top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.162: Similar results were observed using affinity-purified FATRIP expressed in mammalian 293T cells (data not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "affinity-purified FATRIP"

Phrase: "expressed in mammalian 293T cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   781   C1512977:Mammalian Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0024660:Mammalian [Mammal]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.163: In order to assess whether ATR itself can bind DNA directly, we first expressed FLAG-tagged ATR (FATR) in mammalian 293T cells. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "whether"

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "itself"

Phrase: "can"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA directly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "we first expressed FLAG-tagged ATR (FATR)"

Phrase: "in mammalian 293T cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C1512977:Mammalian Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.164: Prior to purification, both wild-type and kinase-inactive versions of FATR in a nuclear extract prepared from 293T cells bound to ssDNA cellulose and eluted under the same conditions observed for endogenous ATR (Fig. 6A, top right panel and data not shown). 

Phrase: "Prior to purification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "both wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "kinase-inactive versions of FATR"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0333052:versions [Functional Concept]
   714 E C2607870:Version [Spatial Concept]

Phrase: "in a nuclear extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   861   C2828366:Extract [Substance]

Phrase: "prepared from 293T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1521827:Prepare [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "bound to ssDNA cellulose"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "eluted under the same conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0445247:Same [Qualitative Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "observed for endogenous ATR (Fig. 6A,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205227:Endogenous [Functional Concept]
   753   C0349966:Fig [Food]
   753   C1337208:FIG [Food]
   753   C1441672:Observed [Functional Concept]
   753   C1553638:6a [Medical Device]
   753   C3540546:ATR [Gene or Genome]

Phrase: "top right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.165: However, when FATR was affinity purified and then applied to ssDNA cellulose, we found that the majority of the purified FATR, like FATRIP, could not bind to DNA (Fig. 4A, bottom panel). 

Phrase: "However,"

Phrase: "when"

Phrase: "FATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540546:ATR [Gene or Genome]

Phrase: "was"

Phrase: "affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "applied to ssDNA cellulose,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   770   C0185125:Applied [Health Care Activity]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the majority of the purified FATR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0680220:majority [Social Behavior]

Phrase: "like FATRIP,"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind to DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.166: The ability of affinity-purified FATR to undergo autophosphorylation (data not shown) and to phosphorylate a GST-Rad17 substrate peptide (29) suggests that the purified ATR is active as a kinase and is properly folded (Fig. 4B). 

Phrase: "The ability of affinity-purified FATR to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0085732:Ability [Organism Attribute]

Phrase: "undergo"

Phrase: "autophosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0813988:autophosphorylation [Molecular Function]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "phosphorylate"

Phrase: "a GST-Rad17 substrate peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(29"

Phrase: ")"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the purified ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540546:ATR [Gene or Genome]

Phrase: "is"

Phrase: "active as a kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205177:Active [Functional Concept]

Phrase: "and"

Phrase: "is"

Phrase: "properly"

Phrase: "folded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Folded [Spatial Concept]
  1000   C1880834:FOLDED [Phenomenon or Process]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.167: Thus, these results suggest that ATR, like ATRIP, does not bind directly to ssDNA cellulose. 

Phrase: "Thus,"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that ATR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "like ATRIP,"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "directly to ssDNA cellulose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   770   C1947931:Directly [Qualitative Concept]
Processing 00000000.tx.168: View larger version (41K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(41K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.169: 6. 

Phrase: "6."
Processing 00000000.tx.170: ATR is necessary for ATRIP to form a large molecular weight complex that can bind DNA. 

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "is"

Phrase: "necessary for ATRIP to"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a large molecular weight complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "can"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.171: A, nuclear extracts (100 g) prepared from 293T cells expressing FATR (top panel), mycATRIP (second panel), or FATR and mycATRIP (bottom panels) were applied to 100-l ssDNA cellulose columns. 

Phrase: "A,"

Phrase: "nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "(100 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "prepared from 293T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1521827:Prepare [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "FATR (top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0441833:Panel [Idea or Concept]
   804   C1999270:Panel [Intellectual Product]
   804   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "mycATRIP"

Phrase: "(second panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "FATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "mycATRIP"

Phrase: "(bottom panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "were"

Phrase: "applied to 100-l ssDNA cellulose columns."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   748   C0185125:Applied [Health Care Activity]
   714   C1185738:Column [Body Part, Organ, or Organ Component]
   714 E C1632850:Apply [Functional Concept]
   714   C1706132:Column [Idea or Concept]
   714 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.172: The binding of FATR (right panels) or mycATRIP (left panels) was analyzed as described in Fig. 

Phrase: "The binding of FATR (right panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: "or"

Phrase: "mycATRIP"

Phrase: "(left panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.173: 1B. 

Phrase: "1B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]
Processing 00000000.tx.174: B, nuclear extracts prepared from 293T cells expressing mycATRIP alone (left panels) or mycATRIP and FATR (right panels) were loaded onto 530% sucrose density gradients and centrifuged for 3 h at 55,000 rpm. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "prepared from 293T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1521827:Prepare [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "mycATRIP"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(left panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "mycATRIP"

Phrase: "and"

Phrase: "FATR (right panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0441833:Panel [Idea or Concept]
   804   C1999270:Panel [Intellectual Product]
   804   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "were"

Phrase: "loaded onto 530% sucrose density gradients"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0178587:density [Quantitative Concept]
   753   C0812409:gradients [Quantitative Concept]
   753   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   753   C1708715:Loaded [Activity]
   719 E C0439182:% gradient [Quantitative Concept]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]

Phrase: "and"

Phrase: "centrifuged for 3 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0041119:h 3 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0179834:centrifuge [Medical Device]

Phrase: "at 55,000 rpm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0582523:rpm [Quantitative Concept]
Processing 00000000.tx.175: Fractions were taken from the top of the gradient, separated by SDS-PAGE and analyzed by Western blotting with the antibodies indicated. 

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "taken from the top of the gradient,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0439182:% gradient [Quantitative Concept]
   748   C0812409:Gradient [Quantitative Concept]
   748   C1704458:Top [Spatial Concept]
   748   C1883727:Taken [Conceptual Entity]
   714 E C1515187:Take [Health Care Activity]

Phrase: "separated by SDS-PAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with the antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.176: C, fractions 47 and 1518 from the sucrose gradient of the sample expressing both FATR and mycATRIP (B, right panel) were pooled separately then applied to 100-l ssDNA cellulose columns. 

Phrase: "C,"

Phrase: "fractions 47"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "1518 from the sucrose gradient of the sample"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0370003:Sample [Substance]
   744   C0439182:% gradient [Quantitative Concept]
   744   C0812409:Gradient [Quantitative Concept]
   744   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   744   C2347026:Sample [Conceptual Entity]

Phrase: "expressing"

Phrase: "both FATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "mycATRIP"

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: "separately then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "applied to 100-l ssDNA cellulose columns."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   748   C0185125:Applied [Health Care Activity]
   714   C1185738:Column [Body Part, Organ, or Organ Component]
   714 E C1632850:Apply [Functional Concept]
   714   C1706132:Column [Idea or Concept]
   714 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.177: Binding was analyzed as described in Fig. 

Phrase: "Binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.178: 1B and blotted with an anti-Myc antibody.  

Phrase: "1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "blotted with an anti-Myc antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.179: View larger version (23K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.180: 4. 

Phrase: "4."
Processing 00000000.tx.181: ATR and ATRIP require another protein to bind ssDNA in vitro. 

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "require"

Phrase: "another protein to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "ssDNA"

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.182: Affinity-purified FATRIP or FATR in the presence of 100 gof bovine serum albumin were applied to ssDNA cellulose columns separately (A) or after prior incubation (C). 

Phrase: "Affinity-purified FATRIP"

Phrase: "or"

Phrase: "FATR in the presence of 100 gof bovine serum albumin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C3540546:ATR [Gene or Genome]

Phrase: "were"

Phrase: "applied to ssDNA cellulose columns separately"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   753   C0185125:Applied [Health Care Activity]
   719   C1185738:Column [Body Part, Organ, or Organ Component]
   719 E C1632850:Apply [Functional Concept]
   719   C1706132:Column [Idea or Concept]
   719 E C1879355:Apply [Functional Concept]

Phrase: "(A)"

Phrase: "or after prior incubation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332152:Prior [Temporal Concept]
   770   C2826257:PRIOR [Event]

Phrase: "(C"

Phrase: ")."
Processing 00000000.tx.183: B, affinity-purified FATR wild type (FATR-wt) and kinase dead (FATR-kd) were tested in an in vitro kinase assay using GST-Rad17 as a substrate. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "affinity-purified FATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3540546:ATR [Gene or Genome]

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(FATR-wt)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2700323:WT [Fish]

Phrase: "and"

Phrase: "kinase dead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011065:Dead [Organism Function]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(FATR-kd)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0026691:KD [Disease or Syndrome]
   812   C1705240:KD [Gene or Genome]
   812   C1839259:KD [Disease or Syndrome]

Phrase: "were"

Phrase: "tested in an in vitro kinase assay"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   800   C1515653:In Vitro Assay [Research Activity]
   774   C0021135:In Vitro [Intellectual Product]
   774   C1533691:in vitro [Qualitative Concept]
           vitro
   774   C2827718:In Vitro [Functional Concept]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0243073:assay [Qualitative Concept]
   748   C0392366:tested [Intellectual Product]
   748   C1510438:Assay [Laboratory Procedure]
   714 E C0022885:Test [Laboratory Procedure]
   714 E C0039593:Test [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GST-Rad17 as a substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1419232:RAD17 [Gene or Genome]
Processing 00000000.tx.184: Phosphorylation of GST-Rad17 was determined by autoradiography. 

Phrase: "Phosphorylation of GST-Rad17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "determined by autoradiography."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0004400:Autoradiography [Laboratory Procedure]
Processing 00000000.tx.185: Coomassie stain of GST-Rad17 shows equal loading. 

Phrase: "Coomassie stain of GST-Rad17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "equal loading."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]
Processing 00000000.tx.186: D, affinity-purified FATRIP or FATR were preincubated with 100 g of HeLa nuclear extract prior to loading onto ssDNA cellulose columns. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "affinity-purified FATRIP"

Phrase: "or"

Phrase: "FATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540546:ATR [Gene or Genome]

Phrase: "were"

Phrase: "preincubated with 100 g of HeLa nuclear extract"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1518434:Nuclear Extract [Biomedical or Dental Material]
   744   C0018873:HeLa [Cell]
   744   C0439267:g% [Quantitative Concept]
   744   C0521447:Nuclear [Spatial Concept]
   744   C2828366:Extract [Substance]

Phrase: "prior to loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708715:Loading [Activity]

Phrase: "onto ssDNA cellulose columns."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1185738:Column [Body Part, Organ, or Organ Component]
   793   C1706132:Column [Idea or Concept]
Processing 00000000.tx.187: DNA binding in A, C, and D was analyzed as described in Fig. 

Phrase: "DNA binding in A,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1148673:DNA Binding [Genetic Function]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "C,"

Phrase: "and"

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.188: 1B, and proteins were blotted with the anti-FLAG antibody.  

Phrase: "1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "blotted with the anti-FLAG antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C1708067:Flag [Functional Concept]
Processing 00000000.tx.189: Since ATR and ATRIP appear to be part of a single DNA binding complex, it is possible that these two proteins may bind DNA in a cooperative manner. 

Phrase: "Since"

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "part of a single DNA binding complex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1292711:Part of [Spatial Concept]
   748   C0449719:Part [Spatial Concept]
   748   C1709471:Part [Quantitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "these two proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA in a cooperative manner."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.190: To address this question, we preincubated affinity-purified FATR and FATRIP with each other prior to assessing DNA binding. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this question,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "we"

Phrase: "preincubated"

Phrase: "affinity-purified FATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "FATRIP with each other"

Phrase: "prior to assessing DNA binding."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1148673:DNA Binding [Genetic Function]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
Processing 00000000.tx.191: Under these conditions, minimal binding of either protein to ssDNA was observed (Fig. 4C). 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "minimal binding of either protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0033618:Protein Binding [Molecular Function]
   797   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to ssDNA"

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.192: This observation indicates that ATR and ATRIP are not sufficient to form the RPA-independent, lower affinity DNA binding complex. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "indicates"

Phrase: "that ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "are"

Phrase: "not sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "the RPA-independent,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0085862:Independent [Idea or Concept]
   812   C1299583:Independent [Finding]
   756   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1167121:replication protein A [Cell Component]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "affinity DNA binding complex."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C1148673:DNA Binding [Genetic Function]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C0439855:Complex [Qualitative Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.193: We have previously shown that incubation of affinity-purified FATRIP with HeLa nuclear extract can reconstitute the binding of FATRIP to ssDNA (Fig. 2B, bottom panels and Fig. 4D, top panel). 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that incubation of affinity-purified FATRIP"

Phrase: "with HeLa nuclear extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1518434:Nuclear Extract [Biomedical or Dental Material]
   827   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "can"

Phrase: "reconstitute"

Phrase: "the binding of FATRIP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "to ssDNA (Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450354:2b [Intellectual Product]
   827   C1706096:2B [Research Activity]

Phrase: "bottom panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "and"

Phrase: "Fig. 4D, top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0441833:Panel [Idea or Concept]
   812   C1999270:Panel [Intellectual Product]
   812   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.194: Similarly, we found that in vitro translated ATRIP, which does not bind to ssDNA in a reticulocyte extract, associates with ssDNA upon incubation with HeLa nuclear extract (data not shown). 

Phrase: "Similarly,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that in vitro translated ATRIP,"

Phrase: "which"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind to ssDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "in a reticulocyte extract,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828366:Extract [Substance]

Phrase: "associates with ssDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "upon incubation"

Phrase: "with HeLa nuclear extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1518434:Nuclear Extract [Biomedical or Dental Material]
   827   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.195: We also found that the low affinity binding of FATR and in vitro translated ATR could be largely reconstituted by the addition of HeLa nuclear extract (Fig. 4D, bottom panel and data not shown). 

Phrase: "We also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the low affinity binding of FATR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "in vitro translated ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3540546:ATR [Gene or Genome]

Phrase: "could"

Phrase: "be"

Phrase: "largely"

Phrase: "reconstituted by the addition of HeLa nuclear extract"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1518434:Nuclear Extract [Biomedical or Dental Material]
   744   C0018873:HeLa [Cell]
   744   C0521447:Nuclear [Spatial Concept]
   744   C1883712:Addition [Functional Concept]
   744   C2828366:Extract [Substance]

Phrase: "(Fig. 4D, bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0441833:Panel [Idea or Concept]
   812   C1999270:Panel [Intellectual Product]
   812   C3537156:Panel [Manufactured Object]

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.196: The observation that ATR and ATRIP are not sufficient to bind DNA cooperatively and that HeLa nuclear extract is able to reconstitute the low affinity RPA-independent DNA binding suggests that a separate activity is required for association of the ATR-ATRIP complex with DNA. 

Phrase: "The observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "are"

Phrase: "not sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA cooperatively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "that HeLa nuclear extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1518434:Nuclear Extract [Biomedical or Dental Material]
   827   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "reconstitute"

Phrase: "the low affinity RPA-independent DNA binding"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   850   C0033618:Protein Binding [Molecular Function]
   836   C0058610:protein dna [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1148673:DNA Binding [Genetic Function]
   793   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0243122:binding [Functional Concept]
   793   C1145667:Binding [Activity]
   793   C1167622:Binding [Molecular Function]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a separate activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "required for association of the ATR-ATRIP complex"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C2611008:ATR-ATRIP complex [Cell Component]
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0439855:Complex [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]
   744   C1514873:Required [Functional Concept]
   744   C1704241:Complex [Chemical Viewed Structurally]
   744   C3540546:ATR [Gene or Genome]

Phrase: "with DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.197: Because the DNA binding activity remains associated with the ATR-ATRIP complex through several fractionation steps, including gel filtration, it seems unlikely that this factor is a small molecule or ion. 

Phrase: "Because"

Phrase: "the DNA binding activity remains"

Phrase: "associated with the ATR-ATRIP complex"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C2611008:ATR-ATRIP complex [Cell Component]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]
   753   C3540546:ATR [Gene or Genome]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "through several fractionation steps,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C1261552:steps [Conceptual Entity]
   793 E C1704379:Step [Functional Concept]
   793 E C1705117:Step [Quantitative Concept]
   793 E C2825408:Step [Manufactured Object]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "gel filtration,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0008559:Gel Filtration [Laboratory Procedure]
   861   C0016107:filtration [Laboratory Procedure]
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "it"

Phrase: "seems"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "this factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521761:Factor [Functional Concept]
  1000   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "a small molecule"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1328819:Small Molecule [Organic Chemical]
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "or"

Phrase: "ion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022023:Ion [Element, Ion, or Isotope]
  1000   C1700702:ION [Functional Concept]
Processing 00000000.tx.198: To test this more directly, we subjected the HeLa nuclear extract to heat-denaturation and proteolysis. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this more directly,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "we"

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "the HeLa nuclear extract to heat-denaturation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1518434:Nuclear Extract [Biomedical or Dental Material]
   748   C0521447:Nuclear [Spatial Concept]
   748   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "proteolysis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]
Processing 00000000.tx.199: We found that either treatment led to loss of the ability of the nuclear extract to reconstitute the binding of ATR to ssDNA (data not shown). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that either treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "led to loss of the ability of the nuclear extract to"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   756   C1518434:Nuclear Extract [Biomedical or Dental Material]
   738   C0085732:Ability [Organism Attribute]
   738   C0521447:Nuclear [Spatial Concept]
   738   C1517945:Loss [Quantitative Concept]
   738   C1708698:LED [Manufactured Object]
   738   C2828366:Extract [Substance]
   704 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   704 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   704 E C1522538:Lead [Functional Concept]
   704 E C2348269:Lead [Element, Ion, or Isotope]
   704 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "reconstitute"

Phrase: "the binding of ATR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to ssDNA (data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.200: We also found that depletion of ATP had no effect on ATR binding, suggesting that the DNA-binding of ATR is not an ATP-dependent process under our assay conditions (data not shown). 

Phrase: "We also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that depletion of ATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333668:Depletion [Functional Concept]

Phrase: "had"

Phrase: "no effect on ATR binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the DNA-binding of ATR"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1148673:DNA Binding [Genetic Function]
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "an ATP-dependent process under our assay conditions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1184743:Process [Body Part, Organ, or Organ Component]
   744   C1522240:Process [Phenomenon or Process]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.201: Taken together, these results strongly suggest that both ATR and ATRIP require at least one additional protein to reconstitute the DNA binding complex seen upon elution with 400 mM NaCl. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results strongly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "both ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "require at least one additional protein to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205447:One [Quantitative Concept]
   748   C1524062:Additional [Functional Concept]

Phrase: "reconstitute"

Phrase: "the DNA binding complex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1148673:DNA Binding [Genetic Function]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0243122:binding [Functional Concept]
   827   C0439855:Complex [Qualitative Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "seen upon elution"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205397:Seen [Qualitative Concept]
   790   C1441565:Elution [Laboratory Procedure]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "with 400 mM NaCl."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]
Processing 00000000.tx.202: ATRIP Is Not Required for ATR Binding to DNAAlthough ATR and ATRIP are not sufficient to bind DNA, one may still be necessary for the other to bind in the context of the native protein complex. 

Phrase: "ATRIP"

Phrase: "Is"

Phrase: "Not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "Required for ATR Binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1514873:Required [Functional Concept]
   770   C3540546:ATR [Gene or Genome]

Phrase: "to DNAAlthough ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "are"

Phrase: "not sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "may"

Phrase: "still"

Phrase: "be"

Phrase: "necessary for the"

Phrase: "other to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind in the context of the native protein complex."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1523872:protein complex [Cell Component]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0302891:Native [Functional Concept]
   742   C0439855:Complex [Qualitative Concept]
   742   C0449255:Context [Finding]
   742   C0542559:Context [Functional Concept]
   742   C1145667:Bind [Activity]
   742   C1167622:bind [Molecular Function]
   742   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.203: As noted previously, studies in budding yeast have shown that Lcd1/Ddc2 is required for the association of Mec1 with DNA in vitro (21). 

Phrase: "As"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "previously,"

Phrase: "studies in budding yeast"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0014181:Yeast, Budding [Fungus]
   819 E C1961113:Yeast.budding [Fungus]
   770   C0036025:yeast [Fungus]
   770   C0043392:Yeast [Food]
   770   C0043393:Yeast [Fungus]
   770   C0557651:Study [Manufactured Object]
   770   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   770   C0947630:studies [Laboratory Procedure]
   770   C1155616:budding [Cell Function]
   770   C2603343:Study [Research Activity]
   737 E C2700462:Bud [Plant]
   737 E C2945744:bud [Anatomical Structure]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Lcd1/Ddc2"

Phrase: "is"

Phrase: "required for the association of Mec1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]
   753   C1332120:MEC1 [Gene or Genome]
   753   C1514873:Required [Functional Concept]

Phrase: "with DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.204: To determine if ATRIP is necessary for the association of ATR with DNA, we prepared a cell lysate containing ATR, but lacking ATRIP. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "ATRIP"

Phrase: "is"

Phrase: "necessary for the association of ATR"

Phrase: "with DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "we"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "a cell lysate containing ATR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3540546:ATR [Gene or Genome]

Phrase: "but"

Phrase: "lacking ATRIP."
Processing 00000000.tx.205: Because the majority of ATR coprecipitates with ATRIP upon ATRIP depletion (24), we first transfected 293T cells with ATR to create a pool of ATR in the cells that was not bound to ATRIP. 

Phrase: "Because"

Phrase: "the majority of ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "coprecipitates with ATRIP"

Phrase: "upon ATRIP depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333668:Depletion [Functional Concept]

Phrase: "(24"

Phrase: ")"

Phrase: ","

Phrase: "we first transfected 293T cells with ATR to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "a pool of ATR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0337051:Pool [Geographic Area]
   770   C1509144:pool [Clinical Attribute]
   770   C2349200:Pool [Functional Concept]

Phrase: "in the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bound to ATRIP."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]
Processing 00000000.tx.206: We then removed ATRIP from a nuclear extract prepared from these cells using an anti-ATRIP antibody (Fig. 5A). 

Phrase: "We then removed ATRIP from a nuclear extract"

Phrase: "prepared from these cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1521827:Prepare [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an anti-ATRIP antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.207: Depletion of ATRIP led to generation of an extract containing 6070% of the ATR present before depletion. 

Phrase: "Depletion of ATRIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0333668:Depletion [Functional Concept]

Phrase: "led to generation of an extract"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   753   C0079411:Generation [Temporal Concept]
   753   C1708698:LED [Manufactured Object]
   753   C2828366:Extract [Substance]
   753   C3146294:Generation [Activity]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C1522538:Lead [Functional Concept]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "6070% of the ATR present"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C3540546:ATR [Gene or Genome]

Phrase: "before depletion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333668:Depletion [Functional Concept]
Processing 00000000.tx.208: Using this ATRIP-depleted extract, we assessed the ability of the remaining ATR to bind ssDNA cellulose and elute at 400 mM salt. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this ATRIP-depleted extract,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "we"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the ability of the remaining ATR to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "ssDNA cellulose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]

Phrase: "and"

Phrase: "elute at 400 mM salt."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036140:Salt [Chemical Viewed Structurally]
   760   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0206136:Salt [Food,Inorganic Chemical]
Processing 00000000.tx.209: Importantly, we found that this ATRIP-free pool of ATR was able to bind ssDNA as well as ATR in the mock-depleted extract (Fig. 5B). 

Phrase: "Importantly,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "this ATRIP-free pool of ATR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0337051:Pool [Geographic Area]
   753   C1509144:pool [Clinical Attribute]
   753   C2349200:Pool [Functional Concept]

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "ssDNA"

Phrase: "as well as"

Phrase: "ATR in the mock-depleted extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3540546:ATR [Gene or Genome]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.210: This observation suggests that ATRIP is not necessary for the interaction of ATR with DNA in the lower affinity, RPA-independent DNA binding complex. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that ATRIP"

Phrase: "is"

Phrase: "not necessary for the interaction of ATR"

Phrase: "with DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in the lower affinity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "RPA-independent DNA binding complex."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   879   C2246376:protein-DNA complex [Cell Component]
   877   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   877   C1523872:protein complex [Cell Component]
   861   C0033618:Protein Binding [Molecular Function]
   845   C0058610:protein dna [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1148673:DNA Binding [Genetic Function]
   795   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0243122:binding [Functional Concept]
   795   C0439855:Complex [Qualitative Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.211: View larger version (31K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.212: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.213: ATRIP is not required for ATR to bind DNA in vitro. 

Phrase: "ATRIP"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "required for ATR to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1514873:Required [Functional Concept]
   770   C3540546:ATR [Gene or Genome]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.214: A, a nuclear extract prepared from 293T cells expressing FATR was subjected to three rounds of immunodepletion with anti-ATRIP antibodies. 

Phrase: "A,"

Phrase: "a nuclear extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   861   C2828366:Extract [Substance]

Phrase: "prepared from 293T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1521827:Prepare [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "FATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540546:ATR [Gene or Genome]

Phrase: "was"

Phrase: "subjected to three rounds of immunodepletion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205449:Three [Quantitative Concept]
   719   C0332490:Round [Spatial Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "with anti-ATRIP antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.215: ATR and ATRIP protein remaining in the extract were analyzed after SDS-PAGE and blotted with the indicated antibodies. 

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP protein remaining in the extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1527428:Remaining [Qualitative Concept]

Phrase: "were"

Phrase: "analyzed after SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "blotted with the indicated antibodies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C1444656:Indicated [Finding]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.216: B, nuclear extracts prepared from 293T cells expressing FATR and subjected to mock-depletion (top panels) or three rounds of ATRIP-depletion (bottom panels) were applied to ssDNA cellulose columns as described in Fig. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "prepared from 293T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1521827:Prepare [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "FATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mock-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0562577:mock [Finding]

Phrase: "depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333668:Depletion [Functional Concept]

Phrase: "(top panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "three rounds of ATRIP-depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0332490:Round [Spatial Concept]

Phrase: "(bottom panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "were"

Phrase: "applied to ssDNA cellulose columns"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   760   C0185125:Applied [Health Care Activity]
   726   C1185738:Column [Body Part, Organ, or Organ Component]
   726 E C1632850:Apply [Functional Concept]
   726   C1706132:Column [Idea or Concept]
   726 E C1879355:Apply [Functional Concept]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.217: 1B and blotted with the indicated antibodies.  

Phrase: "1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "blotted with the indicated antibodies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C1444656:Indicated [Finding]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.218: ATR Is Necessary for Recruitment of ATRIP to DNA and ATRIP Complex FormationTo test the possibility that ATR is involved in mediating the interaction of ATRIP with DNA, we took advantage of the observation that in a nuclear extract of 293T cells, overexpressed FATR, but not FATRIP or mycATRIP, could bind DNA (Fig. 6A and data not shown). 

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "Is"

Phrase: "Necessary for Recruitment of ATRIP"

Phrase: "to DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "ATRIP Complex FormationTo"

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the possibility"

Phrase: "that ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "is"

Phrase: "involved in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1314939:Involved [Functional Concept]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "the interaction of ATRIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "we"

Phrase: "took"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "advantage of the observation"

Phrase: "that in a nuclear extract of 293T cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C1518434:Nuclear Extract [Biomedical or Dental Material]
   744   C0007634:Cells [Cell]
   744   C0521447:Nuclear [Spatial Concept]
   744   C2828366:Extract [Substance]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressed FATR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3540546:ATR [Gene or Genome]

Phrase: "but"

Phrase: "not FATRIP"

Phrase: "or"

Phrase: "mycATRIP,"

Phrase: "could"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.219: This observation suggests that some protein necessary for the interaction of ATRIP with DNA might be limiting upon overexpression. 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "some protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "necessary for the interaction of ATRIP"

Phrase: "with DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "might"

Phrase: "be"

Phrase: "limiting upon overexpression."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0439801:limiting [Functional Concept]
   790   C1514559:Overexpression [Genetic Function]
   756 E C1549649:Limit [Idea or Concept]
   756 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.220: If this limiting factor was ATR itself, we reasoned that coexpression of ATR with ATRIP might allow the ATRIP to bind DNA. 

Phrase: "If"

Phrase: "this limiting factor"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0439801:limiting [Functional Concept]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]
   827 E C1549649:Limit [Idea or Concept]
   827 E C2349209:Limit [Conceptual Entity]

Phrase: "was"

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "itself,"

Phrase: "we"

Phrase: "reasoned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0392360:Reason [Idea or Concept]

Phrase: "that coexpression of ATR"

Phrase: "with ATRIP"

Phrase: "might"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the ATRIP to"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.221: Thus, we tested the effect of coexpressing FATR on the association of mycATRIP with ssDNA. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the effect of coexpressing FATR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on the association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "of mycATRIP"

Phrase: "with ssDNA."
Processing 00000000.tx.222: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.223: 6A, upon cotransfection of increasing amounts of FATR with mycATRIP, there was a proportional increase in the amount of mycATRIP that bound ssDNA cellulose and eluted at 400 mM salt. 

Phrase: "6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553638:6a [Medical Device]

Phrase: "upon cotransfection"

Phrase: "of increasing amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "of FATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540546:ATR [Gene or Genome]

Phrase: "with mycATRIP,"

Phrase: "there"

Phrase: "was"

Phrase: "a proportional increase in the amount of mycATRIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "that bound ssDNA cellulose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]

Phrase: "and"

Phrase: "eluted at 400 mM salt."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036140:Salt [Chemical Viewed Structurally]
   760   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C0206136:Salt [Food,Inorganic Chemical]
Processing 00000000.tx.224: In contrast, overexpression of FLAG-tagged ATM (FATM) had no effect on the binding of mycATRIP (data not shown), suggesting that the effect of ATR on ATRIP binding is specific to ATR. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "overexpression of FLAG-tagged ATM (FATM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "had"

Phrase: "no effect on the binding of mycATRIP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the effect of ATR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on ATRIP binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "specific to ATR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]
Processing 00000000.tx.225: Our sucrose gradient sedimentation and gel filtration experiments (Fig. 3, A and C) suggest that ATR and ATRIP are in a single, large DNA binding complex, but the inability of overexpressed mycATRIP to bind DNA could indicate that mycATRIP is no longer in this complex. 

Phrase: "Our sucrose gradient sedimentation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597428:Sedimentation [Laboratory Procedure]
   827   C1384604:Sedimentation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "gel filtration experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0008559:Gel Filtration [Laboratory Procedure]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "C"

Phrase: ")"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "are in a single, large DNA binding complex,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C1148673:DNA Binding [Genetic Function]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0037179:Single [Population Group]
   744   C0087136:single [Finding]
   744   C0205171:Single [Quantitative Concept]
   744   C0243122:binding [Functional Concept]
   744   C0439855:Complex [Qualitative Concept]
   744   C0549177:Large [Quantitative Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1551058:Are [Quantitative Concept]
   744   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "but"

Phrase: "the inability of overexpressed mycATRIP to"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "could"

Phrase: "indicate"

Phrase: "that mycATRIP"

Phrase: "is"

Phrase: "no longer in this complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0205166:Long [Qualitative Concept]
   726   C1706317:Long [Qualitative Concept]
Processing 00000000.tx.226: To test this possibility, we examined the size of mycATRIP by sucrose gradient sedimentation. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the size of mycATRIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0456389:size [Spatial Concept]

Phrase: "by sucrose gradient sedimentation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597428:Sedimentation [Laboratory Procedure]
   827   C1384604:Sedimentation [Natural Phenomenon or Process]
Processing 00000000.tx.227: When expressed alone, mycATRIP was found to sediment at a significantly smaller size than the endogenous protein (compare Fig. 6B, left panels to Fig. 3A). 

Phrase: "When"

Phrase: "expressed alone, mycATRIP"

Phrase: "was"

Phrase: "found to sediment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0150312:Found [Quantitative Concept]
   790   C1550099:Sediment [Body Substance]
   756 E C0243095:Find [Finding]

Phrase: "at a significantly smaller size"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0748864:small size [Finding]
   827   C0456389:size [Spatial Concept]

Phrase: "than the endogenous protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "Fig. 6B,"

Phrase: "left panels to Fig. 3A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441833:Panel [Idea or Concept]
   760   C1999270:Panel [Intellectual Product]
   760   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.228: Purified FATRIP also sediments in the same fractions as overexpressed mycATRIP (data not shown). 

Phrase: "Purified FATRIP also sediments in the same fractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1550099:Sediment [Body Substance]

Phrase: "as overexpressed mycATRIP"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.229: To determine if coexpression of ATR caused recruitment of mycATRIP into those fractions containing ATR, we examined the size of FATR and mycATRIP in nuclear extracts expressing both proteins (Fig. 6B, right panels). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "coexpression of ATR"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "recruitment of mycATRIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2949735:Recruitment [Activity]

Phrase: "into those fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "ATR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the size of FATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "mycATRIP in nuclear extracts"

Phrase: "expressing"

Phrase: "both proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 6B,"

Phrase: "right panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.230: Coexpression of FATR with mycATRIP caused a portion of the mycATRIP to shift to those fractions with a density similar to that of the endogenous ATR-ATRIP complex. 

Phrase: "Coexpression of FATR"

Phrase: "with mycATRIP"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a portion of the mycATRIP to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449719:Portion [Spatial Concept]

Phrase: "shift to those fractions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0333051:Shift [Functional Concept]
   770   C1264633:Fractions [Quantitative Concept]
   770   C2347509:Shift [Phenomenon or Process]
   737 E C1554103:Fraction [Idea or Concept]

Phrase: "with a density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "similar to that of the endogenous ATR-ATRIP complex."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.231: The fractions containing this larger mycATRIP complex also contained FATR. 

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "this larger mycATRIP complex also contained FATR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C3540546:ATR [Gene or Genome]
Processing 00000000.tx.232: In contrast, the density distribution of RPA did not change. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the density distribution of RPA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0872250:protein distribution [Cell Function]
   748   C0178587:density [Quantitative Concept]
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.233: These results suggest that ATR is necessary for ATRIP to form a large molecular weight complex. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "is"

Phrase: "necessary for ATRIP to"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a large molecular weight complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.234: To determine if the two mycATRIP populations that we observed after coexpression with FATR had different DNA binding properties, we collected each pool and tested their ability to bind to ssDNA cellulose (Fig. 6C). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "the two mycATRIP populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "that"

Phrase: "we"

Phrase: "observed after coexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "with FATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540546:ATR [Gene or Genome]

Phrase: "had"

Phrase: "different DNA binding properties,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0871161:properties [Qualitative Concept]
   812   C1292721:properties [Functional Concept]
   779 E C1882134:Property [Conceptual Entity]
   779 E C2347695:Property [Entity]

Phrase: "we"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "each pool"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337051:Pool [Geographic Area]
  1000   C1509144:pool [Clinical Attribute]
  1000   C2349200:Pool [Functional Concept]

Phrase: "and"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "bind to ssDNA cellulose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "(Fig. 6C"

Phrase: ")."
Processing 00000000.tx.235: We found that the mycATRIP in the larger, ATR-containing fractions (1518) was able to associate with DNA in the low affinity DNA binding mode. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the mycATRIP in the larger, ATR-containing fractions"

Phrase: "(1518"

Phrase: ")"

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "associate with DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "in the low affinity DNA binding mode."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1513371:Mode [Functional Concept]
   804   C1705738:Mode [Quantitative Concept]
   804   C2347637:Mode [Quantitative Concept]
   804   C2348146:Mode [Quantitative Concept]
Processing 00000000.tx.236: In contrast, the portion of mycATRIP in the fractions that did not contain ATR (47) did not bind DNA. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the portion of mycATRIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449719:Portion [Spatial Concept]

Phrase: "in the fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "that"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "ATR (47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540546:ATR [Gene or Genome]

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.237: Together, these results suggest that ATR itself is necessary for ATRIP to form a complex that binds DNA in vitro.  

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "itself"

Phrase: "is"

Phrase: "necessary for ATRIP to"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.238: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  The mechanism by which the checkpoint kinase ATR detects and is activated by DNA damage is key to understanding how cells respond to the presence of damaged DNA and replication inhibition. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The mechanism by which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "the checkpoint kinase ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540546:ATR [Gene or Genome]

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "and"

Phrase: "is"

Phrase: "activated by DNA damage"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   770   C0010957:Damage [Injury or Poisoning]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1879547:Activated [Activity]
   770   C1883709:Damage [Functional Concept]
   737 E C1515877:Activate [Functional Concept]

Phrase: "is"

Phrase: "key to understanding how cells"

Phrase: "respond to the presence of damaged DNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0012860:damage dna [Cell or Molecular Dysfunction]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   714   C0010957:Damage [Injury or Poisoning]
   714   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "replication inhibition."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]
Processing 00000000.tx.239: To better understand ATR activation, we have investigated how ATR and its associated protein, ATRIP, interact with DNA in vitro. 

Phrase: "To better"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0332272:Better [Qualitative Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205170:Well [Qualitative Concept]
   827 E C3146287:Well [Manufactured Object]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "ATR activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "we"

Phrase: "have"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "how ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "its associated protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "ATRIP,"

Phrase: "interact with DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.240: As previously reported, we have found that mammalian ATR binds chromatin in vivo (13) and ssDNA in vitro (14), and we show here that ATRIP exhibits the same properties. 

Phrase: "As"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: ","

Phrase: "we"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that mammalian ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540546:ATR [Gene or Genome]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "chromatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
  1000   C1325550:chromatin [Cell Component]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(13"

Phrase: ")"

Phrase: "and"

Phrase: "ssDNA"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that ATRIP"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "the same properties."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]
Processing 00000000.tx.241: Importantly, our data indicate that the ATR-ATRIP complex can associate with ssDNA with two different binding affinities in vitro. 

Phrase: "Importantly,"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "the ATR-ATRIP complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2611008:ATR-ATRIP complex [Cell Component]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "can"

Phrase: "associate with ssDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "with two different binding affinities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.242: Recently, it was reported by Zou and Elledge (24) that RPA is both necessary and sufficient for ATRIP to bind DNA oligonucleotides in vitro. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "reported by Zou"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C1709908:Reported By [Group]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "Elledge"

Phrase: "(24"

Phrase: ")"

Phrase: "that RPA"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]

Phrase: "is"

Phrase: "both necessary"

Phrase: "and"

Phrase: "sufficient for ATRIP to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205410:Sufficient [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.243: Our studies support the presence of an RPA-dependent DNA binding mode; 

Phrase: "Our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the presence of an RPA-dependent DNA binding mode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.244: however, we also find that the majority of endogenous ATR and ATRIP can bind to ssDNA cellulose in the absence of RPA. 

Phrase: "however,"

Phrase: "we also"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that"

Phrase: "the majority of endogenous ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "can"

Phrase: "bind to ssDNA cellulose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of RPA."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]
Processing 00000000.tx.245: This RPA-independent complex appears to bind DNA with a lower affinity than that of the RPA-dependent DNA binding complex. 

Phrase: "This RPA-independent complex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1523872:protein complex [Cell Component]
   804   C0439855:Complex [Qualitative Concept]
   804   C1704241:Complex [Chemical Viewed Structurally]
   717   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1167121:replication protein A [Cell Component]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA with a lower affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "than that"

Phrase: "of the RPA-dependent DNA binding complex."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   879   C2246376:protein-DNA complex [Cell Component]
   877   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   877   C1523872:protein complex [Cell Component]
   861   C0033618:Protein Binding [Molecular Function]
   845   C0058610:protein dna [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1148673:DNA Binding [Genetic Function]
   795   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0243122:binding [Functional Concept]
   795   C0439855:Complex [Qualitative Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.246: Since Zou and Elledge performed their studies using a similar buffer, it is unlikely that the two DNA binding modes seen using ssDNA cellulose represent a difference in binding conditions. 

Phrase: "Since"

Phrase: "Zou"

Phrase: "and"

Phrase: "Elledge"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "their studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a similar buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "it"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "the two DNA binding modes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C1513371:Mode [Functional Concept]
   779   C1705738:Mode [Quantitative Concept]
   779   C2347637:Mode [Quantitative Concept]
   779   C2348146:Mode [Quantitative Concept]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ssDNA cellulose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a difference in binding conditions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.247: However, it is possible the multiple modes of DNA binding of the ATR-ATRIP complex represent binding to different DNA structures in the DNA cellulose. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "the multiple modes of DNA binding of the ATR-ATRIP complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   704   C1513371:Mode [Functional Concept]
   704   C1705738:Mode [Quantitative Concept]
   704   C2347637:Mode [Quantitative Concept]
   704   C2348146:Mode [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "binding to different DNA structures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1148673:DNA Binding [Genetic Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "in the DNA cellulose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0058604:DNA-cellulose [Carbohydrate,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
Processing 00000000.tx.248: Our investigation into the factors involved in the low affinity DNA binding mode of ATR-ATRIP focused initially on the two proteins themselves. 

Phrase: "Our investigation into the factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Investigation [Health Care Activity]
   760   C1552578:investigation [Idea or Concept]

Phrase: "involved in the low affinity DNA binding mode of ATR-ATRIP"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   756   C1148673:DNA Binding [Genetic Function]
   738   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0205251:low [Qualitative Concept]
   738   C0243122:binding [Functional Concept]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1299352:Low [Qualitative Concept]
   738   C1314939:Involved [Functional Concept]
   738   C1510827:Affinity [Natural Phenomenon or Process]
   738   C1513371:Mode [Functional Concept]
   738   C1550472:low [Idea or Concept]
   738   C1705738:Mode [Quantitative Concept]
   738   C2347637:Mode [Quantitative Concept]
   738   C2348146:Mode [Quantitative Concept]
   738   C3540546:ATR [Gene or Genome]

Phrase: "focused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205234:Focused [Spatial Concept]
  1000   C1285542:focused [Functional Concept]

Phrase: "initially on the two proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205265:Initially [Temporal Concept]
   760   C0205448:Two [Quantitative Concept]

Phrase: "themselves."
Processing 00000000.tx.249: The results of our analysis indicate that neither the purified, recombinant form of ATR or ATRIP is capable of binding DNA directly in the low affinity mode. 

Phrase: "The results of our analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "neither the purified, recombinant form of ATR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "or"

Phrase: "ATRIP"

Phrase: "is"

Phrase: "capable of binding DNA directly"

Phrase: "in the low affinity mode."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1513371:Mode [Functional Concept]
   827   C1705738:Mode [Quantitative Concept]
   827   C2347637:Mode [Quantitative Concept]
   827   C2348146:Mode [Quantitative Concept]
Processing 00000000.tx.250: Moreover, ATR and ATRIP are not able to bind ssDNA cellulose when mixed together, indicating that they cannot bind DNA in a cooperative manner. 

Phrase: "Moreover,"

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "are"

Phrase: "not able to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]
   827   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "ssDNA cellulose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]

Phrase: "when"

Phrase: "mixed"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205430:Mixed [Functional Concept]
  1000   C3160715:Mixed [Finding]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "they"

Phrase: "cannot"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA in a cooperative manner."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.251: Nevertheless, we have found that ATR is needed for the association of ATRIP with DNA in this low affinity DNA binding mode. 

Phrase: "Nevertheless,"

Phrase: "we"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "is"

Phrase: "needed for the association of ATRIP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0004083:Association [Mental Process]
   753   C0027552:Needed [Qualitative Concept]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0686904:needed [Functional Concept]
   753   C0699792:association [Social Behavior]

Phrase: "with DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in this low affinity DNA binding mode."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1513371:Mode [Functional Concept]
   804   C1705738:Mode [Quantitative Concept]
   804   C2347637:Mode [Quantitative Concept]
   804   C2348146:Mode [Quantitative Concept]
Processing 00000000.tx.252: We found that coexpression of ATR with mycATRIP allowed mycATRIP to bind ssDNA cellulose and to be incorporated into a DNA binding complex with ATR that is indistinguishable from the endogenous ATR-ATRIP complex. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that coexpression of ATR"

Phrase: "with mycATRIP"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "mycATRIP to"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "ssDNA cellulose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "incorporated into a DNA binding complex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1148673:DNA Binding [Genetic Function]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243122:binding [Functional Concept]
   753   C0439855:Complex [Qualitative Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "with ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "that"

Phrase: "is"

Phrase: "indistinguishable from the endogenous ATR-ATRIP complex."
Processing 00000000.tx.253: We also showed that depletion of ATRIP from a nuclear extract has no effect on the low affinity interaction of ATR with ssDNA cellulose. 

Phrase: "We also"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that depletion of ATRIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333668:Depletion [Functional Concept]

Phrase: "from a nuclear extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   861   C2828366:Extract [Substance]

Phrase: "has"

Phrase: "no effect on the low affinity interaction of ATR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1301751:No effect [Qualitative Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "with ssDNA cellulose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
Processing 00000000.tx.254: Taken together, these results indicate that ATR is a component of a complex through which ATRIP associates to bind DNA. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "is"

Phrase: "a component of a complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "through which ATRIP"

Phrase: "associates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.255: This is in contrast with two recent studies, one in S. cerevisiae which indicates Lcd1 can bind DNA directly (21) and another in S. pombe which shows that Rad26 can localize to DNA damage-induced foci in the absence of Rad3 (17). 

Phrase: "This"

Phrase: "is in contrast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1979874:Contrast [Qualitative Concept]

Phrase: "with two recent studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "one in S. cerevisiae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "which"

Phrase: "indicates"

Phrase: "Lcd1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1690006:LCD1 [Disease or Syndrome]
  1000   C1704975:LCD1 [Gene or Genome]

Phrase: "can"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(21"

Phrase: ")"

Phrase: "and"

Phrase: "another in S. pombe"

Phrase: "which"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that Rad26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366757:RAD26 [Gene or Genome]

Phrase: "can"

Phrase: "localize to DNA damage-induced foci"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   820   C3159064:DNA damage foci [Cell Component]
   790   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   753   C0010957:Damage [Injury or Poisoning]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205234:Foci [Spatial Concept]
   753   C0205263:Induced [Functional Concept]
   753   C0392752:localize [Spatial Concept]
   753   C1883709:Damage [Functional Concept]
   719 E C1285542:focus [Functional Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of Rad3"

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.256: However, our findings are consistent with another study in S. cerevisiae that indicates Mec1 is necessary for Lcd1 to be recruited to HO endonuclease- or cdc13-induced nuclear foci (22). 

Phrase: "However,"

Phrase: "our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with another study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in S. cerevisiae"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036025:S cerevisiae [Fungus]

Phrase: "that"

Phrase: "indicates"

Phrase: "Mec1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332120:MEC1 [Gene or Genome]

Phrase: "is"

Phrase: "necessary for Lcd1 to"

Phrase: "be"

Phrase: "recruited to HO endonuclease-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0014230:endonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1832110:HO [Gene or Genome]

Phrase: "or"

Phrase: "cdc13-induced nuclear foci"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0205234:Foci [Spatial Concept]
   779 E C1285542:focus [Functional Concept]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.257: The inability of purified ATR and ATRIP to bind DNA in vitro suggests that at least one additional DNA binding protein or cofactor is required for the low affinity binding. 

Phrase: "The inability of purified ATR"

Phrase: "and"

Phrase: "ATRIP to"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that at least one additional DNA binding protein"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   800   C0012940:DNA Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C0812382:DNA-binding protein [Gene or Genome]
   770   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1148673:DNA Binding [Genetic Function]
   767 E C0033618:Protein Binding [Molecular Function]
   767   C0058610:protein dna [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205447:One [Quantitative Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1524062:Additional [Functional Concept]

Phrase: "or"

Phrase: "cofactor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178555:Cofactor [Biologically Active Substance]

Phrase: "is"

Phrase: "required for the low affinity binding."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0205251:low [Qualitative Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1299352:Low [Qualitative Concept]
   753   C1510827:Affinity [Natural Phenomenon or Process]
   753   C1514873:Required [Functional Concept]
   753   C1550472:low [Idea or Concept]
Processing 00000000.tx.258: Consistent with this hypothesis, we found that the addition of HeLa nuclear extract to purified ATR or ATRIP was able to reconstitute the binding of purified ATR and ATRIP to DNA. 

Phrase: "Consistent with this hypothesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the addition of HeLa nuclear extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883712:Addition [Functional Concept]

Phrase: "to purified ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540546:ATR [Gene or Genome]

Phrase: "or"

Phrase: "ATRIP"

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "reconstitute"

Phrase: "the binding of purified ATR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "ATRIP to DNA."
Processing 00000000.tx.259: Moreover, our studies of the reconstituting activity suggest that it is a protein since it is protease-sensitive, heat labile, and able to survive gel filtration and other fractionation steps. 

Phrase: "Moreover,"

Phrase: "our studies of the reconstituting activity"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C2348552:Study Activity [Research Activity]
   753   C0947630:studies [Laboratory Procedure]
   731 E C2347179:Active Study [Functional Concept]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "a protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "since"

Phrase: "it"

Phrase: "is"

Phrase: "protease-sensitive, heat labile,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "survive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0310255:SURVIVE [Pharmacologic Substance]

Phrase: "gel filtration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0008559:Gel Filtration [Laboratory Procedure]
   861   C0016107:filtration [Laboratory Procedure]
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "other fractionation steps."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]
Processing 00000000.tx.260: Our data also indicate that both ATR and ATRIP are part of a large molecular weight complex that likely contains the associated activity required for the low affinity ssDNA cellulose binding, since ATR and ATRIP are still able to bind ssDNA after multiple purification steps. 

Phrase: "Our data also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that"

Phrase: "both ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "are"

Phrase: "part of a large molecular weight complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1292711:Part of [Spatial Concept]
   748   C0449719:Part [Spatial Concept]
   748   C1709471:Part [Quantitative Concept]

Phrase: "that likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the associated activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "required for the low affinity ssDNA cellulose binding,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C1148584:cellulose binding [Molecular Function]
   767   C1148754:ssDNA binding [Genetic Function]
   744   C0007648:Cellulose [Biologically Active Substance,Carbohydrate]
   744   C0205251:low [Qualitative Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1299352:Low [Qualitative Concept]
   744   C1510827:Affinity [Natural Phenomenon or Process]
   744   C1514873:Required [Functional Concept]
   744   C1550472:low [Idea or Concept]

Phrase: "since"

Phrase: "ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540546:ATR [Gene or Genome]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "are"

Phrase: "still able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "ssDNA after multiple purification steps."
Processing 00000000.tx.261: Since RPA does not co-purify with the complex as determined by both gel filtration and sucrose density gradient sedimentation, it seems unlikely that this activity involves RPA, although we cannot rule out the possibility that a small amount of RPA below our limits of detection may contribute to this binding in vitro. 

Phrase: "Since"

Phrase: "RPA"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "co-purify with the complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "as"

Phrase: "determined by both gel filtration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0008559:Gel Filtration [Laboratory Procedure]
   760   C0016107:filtration [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "sucrose density gradient sedimentation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0597428:Sedimentation [Laboratory Procedure]
   812   C1384604:Sedimentation [Natural Phenomenon or Process]

Phrase: "it"

Phrase: "seems"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "this activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "involves"

Phrase: "RPA,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]

Phrase: "although"

Phrase: "we"

Phrase: "cannot"

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "a small amount of RPA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "below our limits"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0439801:limits [Functional Concept]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]
   916 E C3542948:Limited [Intellectual Product]

Phrase: "of detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "contribute to this binding in vitro."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1880177:Contribute [Activity]
Processing 00000000.tx.262: Lack of co-fractionation between RPA and ATR-ATRIP by size also does not exclude the possibility that they form a complex on chromatin in vivo. 

Phrase: "Lack of co-fractionation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "between RPA"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]

Phrase: "and"

Phrase: "ATR-ATRIP by size also"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that"

Phrase: "they"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a complex on chromatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439855:Complex [Qualitative Concept]
   770   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.263: Additional purification will be necessary to identify the protein(s) activity needed for ATR-ATRIP to bind DNA. 

Phrase: "Additional purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243114:purification [Functional Concept]
   861   C1998793:Purification [Functional Concept]

Phrase: "will"

Phrase: "be"

Phrase: "necessary to"

Phrase: "identify"

Phrase: "the protein(s"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418948:PROTEIN S [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "needed for ATR-ATRIP to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0027552:Needed [Qualitative Concept]
   760   C0686904:needed [Functional Concept]
   760   C3540546:ATR [Gene or Genome]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.264: One interesting candidate is the replication protein TOPBP1 (xCut5) that was recently shown to be required for ATR to bind poly(dA) oligonucleotides in Xenopus extracts (35). 

Phrase: "One interesting candidate"

Phrase: "is"

Phrase: "the replication protein TOPBP1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0671110:TOPBP1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1336660:TOPBP1 [Gene or Genome]

Phrase: "(xCut5"

Phrase: ")"

Phrase: "that"

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "required for ATR to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1514873:Required [Functional Concept]
   770   C3540546:ATR [Gene or Genome]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "poly(dA) oligonucleotides in Xenopus extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.265: Although the physiological significance of ATR-ATRIP's lower affinity, RPA-independent DNA binding is not yet known, one interesting possibility is that the two modes of DNA binding seen in vitro reflect differences in binding to chromatin in vivo. 

Phrase: "Although"

Phrase: "the physiological significance of ATR-ATRIP's"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237881:Significance [Quantitative Concept]
   753   C0750502:Significance [Idea or Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "affinity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "RPA-independent DNA binding"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   876   C0033618:Protein Binding [Molecular Function]
   858   C0058610:protein dna [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1148673:DNA Binding [Genetic Function]
   799   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "one interesting possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   755   C0332149:Possible [Qualitative Concept]
   755   C1705910:Possible [Qualitative Concept]
   755   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "the two modes of DNA binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C1513371:Mode [Functional Concept]
   719   C1705738:Mode [Quantitative Concept]
   719   C2347637:Mode [Quantitative Concept]
   719   C2348146:Mode [Quantitative Concept]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "differences in binding"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "to chromatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
  1000   C1325550:chromatin [Cell Component]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.266: Prior to DNA damage, there may be loose association of the ATR-ATRIP complex with chromatin, facilitating a more rapid response to DNA damage. 

Phrase: "Prior to DNA damage,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "there"

Phrase: "may"

Phrase: "be"

Phrase: "loose association of the ATR-ATRIP complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0240233:loose association [Finding]
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "with chromatin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
  1000   C1325550:chromatin [Cell Component]

Phrase: "facilitating"

Phrase: "a more rapid response to DNA damage."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1155291:DNA damage response [Cell Function]
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]
Processing 00000000.tx.267: This hypothesis is consistent with the finding that both proteins bind chromatin in the absence of genotoxic stress. 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "consistent with the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
   783   C0332529:Consistency finding [Qualitative Concept]

Phrase: "that"

Phrase: "both proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "chromatin in the absence of genotoxic stress."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
   748   C1325550:chromatin [Cell Component]
Processing 00000000.tx.268: Interestingly, however, a dramatic intranuclear relocalization of ATR, ATRIP, and RPA is observed following DNA damage (24, 25). 

Phrase: "Interestingly,"

Phrase: "however,"

Phrase: "a dramatic intranuclear relocalization of ATR,"

Phrase: "ATRIP,"

Phrase: "and"

Phrase: "RPA"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]

Phrase: "is"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.269: This behavior may represent a change in the manner with which both proteins bind chromatin. 

Phrase: "This behavior"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0004927:Behavior [Individual Behavior]
  1000   C2707008:Behavior [Clinical Attribute]
   928 E C2986890:Behavioral [Idea or Concept]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a change in the manner"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "with which"

Phrase: "both proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "chromatin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
  1000   C1325550:chromatin [Cell Component]
Processing 00000000.tx.270: Indeed, the amount of chromatin-bound RPA significantly increases in both Xenopus (6) and mammalian systems (24) following DNA damage, suggesting an increase in the amount of single-stranded DNA at sites of DNA damage. 

Phrase: "Indeed,"

Phrase: "the amount of chromatin-bound RPA significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1265611:Amount [Quantitative Concept]

Phrase: "increases in both Xenopus"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0043342:Xenopus [Amphibian]
   770   C0043343:Xenopus [Amphibian]
   770   C0442805:Increase [Functional Concept]
   770   C1504663:Xenopus [Amphibian]
   715 E C1517378:Gain [Quantitative Concept]

Phrase: "(6"

Phrase: ")"

Phrase: "and"

Phrase: "mammalian systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "(24"

Phrase: ")"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "DNA damage,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "an increase in the amount of single-stranded DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "at sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "of DNA damage."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]
Processing 00000000.tx.271: However, the level of ATR and ATRIP recruited to chromatin in asynchronous mammalian cells does not increase following DNA damage (data not shown). 

Phrase: "However,"

Phrase: "the level of ATR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "recruited to chromatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
   790   C1325550:chromatin [Cell Component]

Phrase: "in asynchronous mammalian cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C1512977:Mammalian Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.272: One possibility is that the increased local concentration of RPA at sites of DNA damage changes the mechanism by which ATR and ATRIP associate with chromatin from a low affinity mode of binding to a higher affinity mode, thereby inducing checkpoint activation. 

Phrase: "One possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "the increased local concentration of RPA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0427716:Protein concentration [Laboratory Procedure]
   767   C1304757:Protein concentration [Laboratory or Test Result]
   744   C0086045:Concentration [Mental Process]
   744   C1446561:Concentration [Quantitative Concept]

Phrase: "at sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "of DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the mechanism by which ATR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "ATRIP"

Phrase: "associate with chromatin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
   790   C0750490:Associate [Idea or Concept]
   790   C1325550:chromatin [Cell Component]
   790   C1706221:Associate [Professional or Occupational Group]

Phrase: "from a low affinity mode"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1513371:Mode [Functional Concept]
   827   C1705738:Mode [Quantitative Concept]
   827   C2347637:Mode [Quantitative Concept]
   827   C2348146:Mode [Quantitative Concept]

Phrase: "of binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "to a higher affinity mode,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1513371:Mode [Functional Concept]
   827   C1705738:Mode [Quantitative Concept]
   827   C2347637:Mode [Quantitative Concept]
   827   C2348146:Mode [Quantitative Concept]

Phrase: "thereby"

Phrase: "inducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Inducing [Functional Concept]

Phrase: "checkpoint activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]
Processing 00000000.tx.273: Further work will be required to understand these distinct binding modes and to identify the other protein(s) involved in mediating the interaction of ATR with DNA.  

Phrase: "Further work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "will"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "these distinct binding modes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1513371:Mode [Functional Concept]
   793   C1705738:Mode [Quantitative Concept]
   793   C2347637:Mode [Quantitative Concept]
   793   C2348146:Mode [Quantitative Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the other protein(s"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418948:PROTEIN S [Gene or Genome]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "involved in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1314939:Involved [Functional Concept]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "the interaction of ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.274: FOOTNOTES  * This work was supported by grants from the National Institutes of Health (GM62193) and the American Cancer Society (99-241-01-CCG) (to K. A. C.) and by grants from the National Cancer Institute, DHHS (CA09151) and the California Breast Cancer Research Program of the University of California (167U135) (to D. Y.). 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the National Institutes of Health"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "(GM62193"

Phrase: ")"

Phrase: "and"

Phrase: "the American Cancer Society"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0002455:American Cancer Society [Professional Society]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0037455:society [Organization]
   827   C0596070:American [Population Group]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]

Phrase: "(99-241-01-CCG) (to K."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1516476:CCG [Health Care Related Organization]

Phrase: "A. C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: ")"

Phrase: "and by grants"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1515981:And [Idea or Concept]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the National Cancer Institute,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1513882:National Cancer Institute [Health Care Related Organization]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0021622:institute [Organization]
   827   C0998265:Cancer [Eukaryote]
   827   C1272753:Institute [Idea or Concept]
   827   C1306459:Cancer [Finding]
   827   C3245503:national [Intellectual Product]

Phrase: "DHHS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041711:DHHS [Health Care Related Organization]

Phrase: "(CA09151"

Phrase: ")"

Phrase: "and"

Phrase: "the California Breast Cancer Research Program of the University of California"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C1516149:California Breast Cancer Research Program [Health Care Related Organization]
   756   C0683935:research program [Research Activity]
   738   C1709697:Program [Conceptual Entity]
   738   C2728259:Program [Pharmacologic Substance]
   738   C3484370:Program [Functional Concept]

Phrase: "(167U135"

Phrase: ")"

Phrase: "("

Phrase: "to D. Y."

Phrase: ")."
Processing 00000000.tx.275: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.276: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1185738:Column [Body Part, Organ, or Organ Component]
   812   C1706132:Column [Idea or Concept]
Processing 00000000.tx.277: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.278: These authors contributed equally to this article. 

Phrase: "These authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this article."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1706852:Article [Intellectual Product]
Processing 00000000.tx.279: To whom correspondence should be addressed. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.280: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.281: 650-498-4720; 

Phrase: "650-498-4720"

Phrase: ";"
Processing 00000000.tx.282: Fax: 650-725-4665; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "650-725-4665"

Phrase: ";"
Processing 00000000.tx.283: E-mail: cimprich{at}stanford.edu . 1 The abbreviations used are: PIK-related, phosphatidylinositol kinase-related; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "cimprich{at}stanford.edu . 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "PIK-related, phosphatidylinositol kinase-related"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   799   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C2348046:Phosphatidylinositol [Lipid]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0869014:Relations [Social Behavior]

Phrase: ";"
Processing 00000000.tx.284: DTT, dithiothreitol; 

Phrase: "DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.285: PMSF, phenylmethylsulfonyl fluoride; 

Phrase: "PMSF,"

Phrase: "phenylmethylsulfonyl fluoride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.286: RPA, replication protein A; 

Phrase: "RPA,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]

Phrase: "replication protein A"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0165675:Replication Protein A [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167121:replication protein A [Cell Component]
   901   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0598312:Replication [Genetic Function]
   827   C1883725:replication [Qualitative Concept]
   755 E C0205173:Replicate [Functional Concept]
   755 E C0205341:Replicate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.287: ssDNA, single-stranded DNA; 

Phrase: "ssDNA,"

Phrase: "single-stranded DNA"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0012935:DNA, Single-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   865   C1979975:Single strand [Qualitative Concept]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   755   C1704972:Strand [Spatial Concept]
   755   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.288: ATRIP, ATR-interacting protein; 

Phrase: "ATRIP,"

Phrase: "ATR-interacting protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0967200:ATR-Interacting Protein [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2243119:ATR-INTERACTING PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.289: FATR, FLAG-tagged ATR; 

Phrase: "FATR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540546:ATR [Gene or Genome]

Phrase: "FLAG-tagged ATR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540546:ATR [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.290: HEK, human embryonic kidney.  

Phrase: "HEK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0121258:HEK [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C0812263:HEK [Gene or Genome]
  1000   C1704817:HEK [Gene or Genome]

Phrase: "human embryonic kidney."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0013935:Embryonic [Embryonic Structure]
   827   C0022646:Kidney [Body Part, Organ, or Organ Component]
   827   C0086418:Human [Human]
   827   C0227665:kidney [Body Part, Organ, or Organ Component]
   827   C1278978:Kidney [Body Part, Organ, or Organ Component]
   827   C1514845:KIDNEY [Tissue]
   734 E C0027697:Nephritides [Disease or Syndrome]
Processing 00000000.tx.291: ACKNOWLEDGMENTS  We thank Dr. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.292: Karen Pan for helpful preliminary studies. 

Phrase: "Karen Pan for helpful preliminary studies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085999:Pan [Mammal]
Processing 00000000.tx.293: We would also like to thank Dr. 

Phrase: "We"

Phrase: "would"

Phrase: "also like to"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.294: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.295: Elledge for the ATRIP antibody and cDNA and Dr. 

Phrase: "Elledge for the ATRIP antibody"

Phrase: "and"

Phrase: "cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.296: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.297: Wold for the RPA cDNA.  

Phrase: "Wold for the RPA cDNA."
Processing 00000000.tx.298: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Zhou, B. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Zhou,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.299: B., and Elledge, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Elledge,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.300: J. 

Phrase: "J."
Processing 00000000.tx.301: (2000) Nature 408, 433439[CrossRef][Medline] [OrderarticleviaInfotrieve] Melo, J., and Toczyski, D. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nature 408,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "433439"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Melo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3098072:Melo [Eukaryote]

Phrase: "J.,"

Phrase: "and"

Phrase: "Toczyski,"

Phrase: "D."
Processing 00000000.tx.302: (2002) Curr. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.303: Opin. 

Phrase: "Opin."
Processing 00000000.tx.304: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.305: 14, 237245[CrossRef][Medline] [OrderarticleviaInfotrieve] Abraham, R. 

Phrase: "14,"

Phrase: "237245"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Abraham,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442982:Abraham [Intellectual Product]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.306: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.307: (2001) Genes Dev. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.308: 15, 21772196[Free FullText] Smith, G. 

Phrase: "15,"

Phrase: "21772196"

Phrase: "[Free FullText"

Phrase: "] Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.309: C. 

Phrase: "C."
Processing 00000000.tx.310: M., and Jackson, S. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Jackson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.311: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.312: (1999) Genes Dev. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.313: 13, 916934[Free FullText] Cliby, W. 

Phrase: "13,"

Phrase: "916934"

Phrase: "[Free FullText"

Phrase: "] Cliby,"

Phrase: "W."
Processing 00000000.tx.314: A., Roberts, C. 

Phrase: "A.,"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "C."
Processing 00000000.tx.315: J., Cimprich, K. 

Phrase: "J.,"

Phrase: "Cimprich,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.316: A., Stringer, C. 

Phrase: "A.,"

Phrase: "Stringer,"

Phrase: "C."
Processing 00000000.tx.317: M., Lamb, J. 

Phrase: "M."

Phrase: ","

Phrase: "Lamb,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0452875:Lamb [Food]
  1000   C1123019:lamb [Mammal]
  1000   C1145701:L-AmB [Antibiotic,Organic Chemical]
  1000   C3496086:Lamb [Organic Chemical,Pharmacologic Substance]

Phrase: "J."
Processing 00000000.tx.318: R., Schreiber, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Schreiber,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.319: L., and Friend, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]

Phrase: "and"

Phrase: "Friend,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079382:friend [Population Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.320: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.321: (1998) EMBO J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.322: 17, 159169[Abstract/Free FullText] Lupardus, P. 

Phrase: "17,"

Phrase: "159169"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lupardus,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.323: J., Byun, T., Yee, M. 

Phrase: "J.,"

Phrase: "Byun,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.324: C., Hekmat-Nejad, M., and Cimprich, K. 

Phrase: "C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "Hekmat-Nejad,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Cimprich,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.325: A. 

Phrase: "A."
Processing 00000000.tx.326: (2002) Genes Dev. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.327: 16, 23272332[Abstract/Free FullText] Stokes, M. 

Phrase: "16,"

Phrase: "23272332"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stokes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551086:Stokes [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.328: P., Van Hatten, R., Lindsay, H. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Van Hatten,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lindsay,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.329: D., and Michael, W. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Michael,"

Phrase: "W."
Processing 00000000.tx.330: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.331: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.332: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.333: 158, 863872[Abstract/Free FullText] Hammarsten, O., and Chu, G. 

Phrase: "158,"

Phrase: "863872"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hammarsten,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Chu,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.334: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.335: Natl. 

Phrase: "Natl."
Processing 00000000.tx.336: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.337: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.338: U. 

Phrase: "U."
Processing 00000000.tx.339: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.340: A. 

Phrase: "A."
Processing 00000000.tx.341: 95, 525530[Abstract/Free FullText] Hammarsten, O., DeFazio, L. 

Phrase: "95,"

Phrase: "525530"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hammarsten,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "DeFazio,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]
Processing 00000000.tx.342: G., and Chu, G. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Chu,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.343: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.344: Biol. 

Phrase: "Biol."
Processing 00000000.tx.345: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.346: 275, 15411550[Abstract/Free FullText] Smith, G. 

Phrase: "275,"

Phrase: "15411550"

Phrase: "[Abstract/Free FullText"

Phrase: "] Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.347: C. 

Phrase: "C."
Processing 00000000.tx.348: M., Cary, R. 

Phrase: "M."

Phrase: ","

Phrase: "Cary,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.349: B., Lakin, N. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lakin,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.350: D., Hann, B. 

Phrase: "D."

Phrase: ","

Phrase: "Hann,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.351: C., Teo, S. 

Phrase: "C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "Teo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.352: H., Chen, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "D."
Processing 00000000.tx.353: J., and Jackson, S. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Jackson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.354: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.355: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.356: Natl. 

Phrase: "Natl."
Processing 00000000.tx.357: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.358: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.359: U. 

Phrase: "U."
Processing 00000000.tx.360: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.361: A. 

Phrase: "A."
Processing 00000000.tx.362: 96, 1113411139[Abstract/Free FullText] Suzuki, K., Kodama, S., and Watanabe, M. 

Phrase: "96,"

Phrase: "1113411139"

Phrase: "[Abstract/Free FullText"

Phrase: "] Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kodama,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Watanabe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.363: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.364: Biol. 

Phrase: "Biol."
Processing 00000000.tx.365: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.366: 274, 2557125575[Abstract/Free FullText] Hekmat-Nejad, M., You, Z., Yee, M.-C., Newport, J., and Cimprich, K. 

Phrase: "274,"

Phrase: "2557125575"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hekmat-Nejad,"

Phrase: "M."

Phrase: ","

Phrase: "You,"

Phrase: "Z.,"

Phrase: "Yee,"

Phrase: "M.-"

Phrase: "C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "Newport,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Cimprich,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.367: A. 

Phrase: "A."
Processing 00000000.tx.368: (2000) Curr. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.369: Biol. 

Phrase: "Biol."
Processing 00000000.tx.370: 10, 15651573[CrossRef][Medline] [OrderarticleviaInfotrieve] Zou, L., Cortez, D., and Elledge, S. 

Phrase: "10,"

Phrase: "15651573"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zou,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]

Phrase: "Cortez,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Elledge,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.371: J. 

Phrase: "J."
Processing 00000000.tx.372: (2002) Genes Dev. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.373: 16, 198208[Abstract/Free FullText] Hall-Jackson, C. 

Phrase: "16,"

Phrase: "198208"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hall-Jackson,"

Phrase: "C."
Processing 00000000.tx.374: A., Cross, D. 

Phrase: "A.,"

Phrase: "Cross,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Cross [Conceptual Entity]

Phrase: "D."
Processing 00000000.tx.375: A. 

Phrase: "A."
Processing 00000000.tx.376: E., Morrice, N., and Smythe, C. 

Phrase: "E.,"

Phrase: "Morrice,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Smythe,"

Phrase: "C."
Processing 00000000.tx.377: (1999) Oncogene 18, 67076713[CrossRef][Medline] [OrderarticleviaInfotrieve] Unsal-Kacmaz, K., Makhov, A. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Oncogene 18,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "67076713"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Unsal-Kacmaz,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Makhov,"

Phrase: "A."
Processing 00000000.tx.378: M., Griffith, J. 

Phrase: "M."

Phrase: ","

Phrase: "Griffith,"

Phrase: "J."
Processing 00000000.tx.379: D., and Sancar, A. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Sancar,"

Phrase: "A."
Processing 00000000.tx.380: (2002) Proc. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.381: Natl. 

Phrase: "Natl."
Processing 00000000.tx.382: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.383: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.384: U. 

Phrase: "U."
Processing 00000000.tx.385: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.386: A. 

Phrase: "A."
Processing 00000000.tx.387: 99, 66736678[Abstract/Free FullText] Edwards, R. 

Phrase: "99,"

Phrase: "66736678"

Phrase: "[Abstract/Free FullText"

Phrase: "] Edwards,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.388: J., Bentley, N. 

Phrase: "J.,"

Phrase: "Bentley,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.389: J., and Carr, A. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Carr,"

Phrase: "A."
Processing 00000000.tx.390: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.391: (1999) Nat. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.392: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.393: 1, 393398[CrossRef][Medline] [OrderarticleviaInfotrieve] Wolkow, T. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "393398"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wolkow,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.394: D., and Enoch, T. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Enoch,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.395: (2003) BMC Genet 4, 6[Medline] [OrderarticleviaInfotrieve] Paciotti, V., Clerici, M., Lucchini, G., and Longhese, M. 

Phrase: "(2003"

Phrase: ")"

Phrase: "BMC Genet 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0065839:BMC [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   827   C0325074:Genet [Mammal]

Phrase: "6"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Paciotti,"

Phrase: "V.,"

Phrase: "Clerici,"

Phrase: "M."

Phrase: ","

Phrase: "Lucchini,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Longhese,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.396: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.397: (2000) Genes Dev. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.398: 14, 20462059[Abstract/Free FullText] Rouse, J., and Jackson, S. 

Phrase: "14,"

Phrase: "20462059"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "Rouse"

Phrase: ","

Phrase: "J.,"

Phrase: "and"

Phrase: "Jackson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.399: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.400: (2000) EMBO J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.401: 19, 58015812[Abstract/Free FullText] Wakayama, T., Kondo, T., Ando, S., Matsumoto, K., and Sugimoto, K. 

Phrase: "19,"

Phrase: "58015812"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wakayama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kondo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ando,"

Phrase: "S."

Phrase: ","

Phrase: "Matsumoto,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Sugimoto,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.402: (2001) Mol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.403: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.404: 21, 755764[Abstract/Free FullText] Rouse, J., and Jackson, S. 

Phrase: "21,"

Phrase: "755764"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "Rouse"

Phrase: ","

Phrase: "J.,"

Phrase: "and"

Phrase: "Jackson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.405: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.406: (2002) Mol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.407: Cell 9, 857869[Medline] [OrderarticleviaInfotrieve] Melo, J. 

Phrase: "Cell 9,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "857869"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Melo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3098072:Melo [Eukaryote]

Phrase: "J."
Processing 00000000.tx.408: A., Cohen, J., and Toczyski, D. 

Phrase: "A.,"

Phrase: "Cohen,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Toczyski,"

Phrase: "D."
Processing 00000000.tx.409: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.410: (2001) Genes Dev. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.411: 15, 28092821[Abstract/Free FullText] Cortez, D., Guntuku, S., Qin, J., and Elledge, S. 

Phrase: "15,"

Phrase: "28092821"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cortez,"

Phrase: "D."

Phrase: ","

Phrase: "Guntuku,"

Phrase: "S."

Phrase: ","

Phrase: "Qin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812297:QIN [Gene or Genome]
  1000   C1705148:QIN [Gene or Genome]

Phrase: "J.,"

Phrase: "and"

Phrase: "Elledge,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.412: J. 

Phrase: "J."
Processing 00000000.tx.413: (2001) Science 294, 17131716[Abstract/Free FullText] Zou, L., and Elledge, S. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Science 294,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "17131716"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zou,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]

Phrase: "and"

Phrase: "Elledge,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.414: J. 

Phrase: "J."
Processing 00000000.tx.415: (2003) Science 300, 15421548[Abstract/Free FullText] Barr, S. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Science 300,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "15421548"

Phrase: "[Abstract/Free FullText"

Phrase: "] Barr,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.416: M., Leung, C. 

Phrase: "M."

Phrase: ","

Phrase: "Leung,"

Phrase: "C."
Processing 00000000.tx.417: G., Chang, E. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Chang,"

Phrase: "E."
Processing 00000000.tx.418: E., and Cimprich, K. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Cimprich,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.419: A. 

Phrase: "A."
Processing 00000000.tx.420: (2003) Curr. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.421: Biol. 

Phrase: "Biol."
Processing 00000000.tx.422: 13, 10471051[CrossRef][Medline] [OrderarticleviaInfotrieve] Dignam, J. 

Phrase: "13,"

Phrase: "10471051"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Dignam,"

Phrase: "J."
Processing 00000000.tx.423: D., Lebovitz, R. 

Phrase: "D."

Phrase: ","

Phrase: "Lebovitz,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.424: M., and Roeder, R. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Roeder,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.425: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.426: (1983) Nucleic Acids Res. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.427: 11, 14751489[Abstract] Mendez, J., and Stillman, B. 

Phrase: "11,"

Phrase: "14751489"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mendez,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Stillman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.428: (2000) Mol. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.429: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.430: 20, 86028612[Abstract/Free FullText] Canman, C. 

Phrase: "20,"

Phrase: "86028612"

Phrase: "[Abstract/Free FullText"

Phrase: "] Canman,"

Phrase: "C."
Processing 00000000.tx.431: E., Lim, D. 

Phrase: "E.,"

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "D."
Processing 00000000.tx.432: S., Cimprich, K. 

Phrase: "S."

Phrase: ","

Phrase: "Cimprich,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.433: A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. 

Phrase: "A.,"

Phrase: "Taya,"

Phrase: "Y.,"

Phrase: "Tamai,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sakaguchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Appella,"

Phrase: "E.,"

Phrase: "Kastan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.434: B., and Siliciano, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Siliciano,"

Phrase: "J."
Processing 00000000.tx.435: D. 

Phrase: "D."
Processing 00000000.tx.436: (1998) Science 281, 16771679[Abstract/Free FullText] Kim, S. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Science 281,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "16771679"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kim,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.437: T., Lim, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "D."
Processing 00000000.tx.438: S., Canman, C. 

Phrase: "S."

Phrase: ","

Phrase: "Canman,"

Phrase: "C."
Processing 00000000.tx.439: E., and Kastan, M. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Kastan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.440: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.441: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.442: Biol. 

Phrase: "Biol."
Processing 00000000.tx.443: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.444: 274, 3753837543[Abstract/Free FullText] Henricksen, L. 

Phrase: "274,"

Phrase: "3753837543"

Phrase: "[Abstract/Free FullText"

Phrase: "] Henricksen,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]
Processing 00000000.tx.445: A., Umbricht, C. 

Phrase: "A.,"

Phrase: "Umbricht,"

Phrase: "C."
Processing 00000000.tx.446: B., and Wold, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Wold,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.447: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.448: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.449: Biol. 

Phrase: "Biol."
Processing 00000000.tx.450: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.451: 269, 1112111132[Abstract/Free FullText] Lee, J., Kumagai, A., and Dunphy, W. 

Phrase: "269,"

Phrase: "1112111132"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee,"

Phrase: "J.,"

Phrase: "Kumagai,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Dunphy,"

Phrase: "W."
Processing 00000000.tx.452: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.453: (2003) Mol. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.454: Cell 11, 329340[Medline] [OrderarticleviaInfotrieve] Costanzo, V., Shechter, D., Lupardus, P. 

Phrase: "Cell 11,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "329340"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Costanzo,"

Phrase: "V.,"

Phrase: "Shechter,"

Phrase: "D."

Phrase: ","

Phrase: "Lupardus,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.455: J., Cimprich, K. 

Phrase: "J.,"

Phrase: "Cimprich,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.456: A., Gottesman, M., and Gautier, J. 

Phrase: "A.,"

Phrase: "Gottesman,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Gautier,"

Phrase: "J."
Processing 00000000.tx.457: (2003) Mol. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.458: Cell 11, 203213[Medline] [OrderarticleviaInfotrieve] Wold, M. 

Phrase: "Cell 11,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "203213"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wold,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.459: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.460: (1997) Annu. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.461: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.462: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.463: 66, 6192[CrossRef][Medline] [OrderarticleviaInfotrieve] Wright, J. 

Phrase: "66,"

Phrase: "6192"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1261259:Wright [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "J."
Processing 00000000.tx.464: A., Keegan, K. 

Phrase: "A.,"

Phrase: "Keegan,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.465: S., Herendeen, D. 

Phrase: "S."

Phrase: ","

Phrase: "Herendeen,"

Phrase: "D."
Processing 00000000.tx.466: R., Bentley, N. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bentley,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.467: J., Carr, A. 

Phrase: "J.,"

Phrase: "Carr,"

Phrase: "A."
Processing 00000000.tx.468: M., Hoekstra, M. 

Phrase: "M."

Phrase: ","

Phrase: "Hoekstra,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.469: F., and Concannon, P. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Concannon,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.470: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.471: Natl. 

Phrase: "Natl."
Processing 00000000.tx.472: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.473: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.474: U. 

Phrase: "U."
Processing 00000000.tx.475: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.476: A. 

Phrase: "A."
Processing 00000000.tx.477: 95, 74457450[Abstract/Free FullText] Parrilla-Castellar, E. 

Phrase: "95,"

Phrase: "74457450"

Phrase: "[Abstract/Free FullText"

Phrase: "] Parrilla-Castellar,"

Phrase: "E."
Processing 00000000.tx.478: R., and Karnitz, L. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Karnitz,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]
Processing 00000000.tx.479: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.480: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.481: Biol. 

Phrase: "Biol."
Processing 00000000.tx.482: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.483: 278, 4550745511[Abstract/Free FullText]

Phrase: "278,"

Phrase: "4550745511"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

